A	O
3	O
'	O
--	O
>	O
5	O
'	O
XPB	B-protein
helicase	I-protein
defect	O
in	O
repair/transcription	B-protein
factor	I-protein
TFIIH	B-protein
of	O
xeroderma	O
pigmentosum	O
group	O
B	O
affects	O
both	O
DNA	O
repair	O
and	O
transcription	O
.	O

XPB	B-protein
is	O
a	O
subunit	O
of	O
the	O
basal	O
transcription	B-protein
factor	I-protein
TFIIH	B-protein
,	O
which	O
is	O
also	O
involved	O
in	O
nucleotide	O
excision	O
repair	O
(	O
NER	O
)	O
and	O
potentially	O
in	O
cell	O
cycle	O
regulation	O
.	O

A	O
frameshift	O
mutation	O
in	O
the	O
3'-end	O
of	O
the	O
XPB	B-DNA
gene	I-DNA
is	O
responsible	O
for	O
a	O
concurrence	O
of	O
two	O
disorders	O
:	O
xeroderma	O
pigmentosum	O
(	O
XP	O
)	O
and	O
Cockayne	O
's	O
syndrome	O
(	O
CS	O
)	O
.	O

We	O
have	O
isolated	O
TFIIH	B-protein
from	O
cells	O
derived	O
from	O
a	O
patient	O
(	O
XP11BE	O
)	O
who	O
carries	O
this	O
frameshift	O
mutation	O
(	O
TFIIHmut	B-protein
)	O
and	O
from	O
the	O
mother	O
of	O
this	O
patient	O
(	O
TFIIHwt	B-protein
)	O
to	O
determine	O
the	O
biochemical	O
consequences	O
of	O
the	O
mutation	O
.	O

Although	O
identical	O
in	O
composition	O
and	O
stoichiometry	O
to	O
TFIIHwt	B-protein
,	O
TFIIHmut	B-protein
shows	O
a	O
reduced	O
3	O
'	O
--	O
>	O
5	O
'	O
XPB	B-protein
helicase	O
activity	O
.	O

A	O
decrease	O
in	O
helicase	O
and	O
DNA-dependent	B-protein
ATPase	I-protein
activities	O
was	O
also	O
observed	O
with	O
the	O
mutated	O
recombinant	O
XPB	B-protein
protein	I-protein
.	O

The	O
XPB	B-protein
mutation	O
causes	O
a	O
severe	O
NER	O
defect	O
.	O

In	O
addition	O
,	O
we	O
provide	O
evidence	O
for	O
a	O
decrease	O
in	O
basal	O
transcription	O
activity	O
in	O
vitro	O
.	O

The	O
latter	O
defect	O
may	O
provide	O
an	O
explanation	O
for	O
many	O
of	O
the	O
XP	O
and	O
CS	O
symptoms	O
that	O
are	O
difficult	O
to	O
rationalize	O
based	O
solely	O
on	O
an	O
NER	O
defect	O
.	O

Thus	O
,	O
this	O
work	O
presents	O
the	O
first	O
detailed	O
analysis	O
of	O
a	O
naturally	O
occurring	O
mutation	O
in	O
a	O
basal	B-protein
transcription	I-protein
factor	I-protein
and	O
supports	O
the	O
concept	O
that	O
the	O
combined	O
XP/CS	O
clinical	O
entity	O
is	O
actually	O
the	O
result	O
of	O
a	O
combined	O
transcription/repair	O
deficiency	O
.	O

THs	NULL
JourNaL	NULL
or	NULL
BroLocicaL	NULL
CHEMISTRY	NULL
©	NULL
1996	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
for	NULL
Biochemistry	NULL
and	NULL
Molecular	NULL
Biology	NULL
,	NULL
Inc.	NULL
Vol	NULL
.	NULL

271	NULL
,	NULL
No	NULL
.	NULL

27	NULL
,	NULL
Issue	NULL
of	NULL
July	NULL
5	NULL
,	NULL
pp	NULL
.	NULL

15898-15904	NULL
,	NULL
1996	NULL
Printed	NULL
in	NULL
U.S.A.	NULL
A	NULL
3	NULL
``	NULL
-	NULL
>	NULL
5	NULL
'	NULL
XPB	NULL
Helicase	NULL
Defect	NULL
in	NULL
Repair/Transcription	NULL
Factor	NULL
TFIIH	NULL
of	NULL
Xeroderma	NULL
Pigmentosum	NULL
Group	NULL
B	NULL
Affects	NULL
Both	NULL
DNA	NULL
Repair	NULL
and	NULL
(	NULL
Received	NULL
for	NULL
publication	NULL
,	NULL
August	NULL
3	NULL
,	NULL
1995	NULL
,	NULL
and	NULL
in	NULL
revised	NULL
form	NULL
,	NULL
March	NULL
31	NULL
,	NULL
1996	NULL
)	NULL
Jae	NULL
Ryoung	NULL
Hwang+	NULL
#	NULL
§	NULL
,	NULL
Vincent	NULL
Moncollint	NULL
,	NULL
Wim	NULL
Vermeulen	NULL
,	NULL
Thierry	NULL
Seroz	NULL
?	NULL

,	NULL
Hanneke	NULL
van	NULL
Vuuren	NULL
,	NULL
Jan	NULL
H.	NULL
J.	NULL
Hoeijmakers	NULL
(	NULL
,	NULL
and	NULL
Jean	NULL
Marc	NULL
Egly	NULL
$	NULL
]	NULL
From	NULL
the	NULL
{	NULL
Institut	NULL
de	NULL
Génétique	NULL
et	NULL
de	NULL
Biologie	NULL
Moléculaire	NULL
et	NULL
Cellulaire	NULL
,	NULL
CNRS/INSERM	NULL
,	NULL
1	NULL
rue	NULL
Laurent	NULL
Fries	NULL
,	NULL
B.	NULL
P.	NULL
163	NULL
,	NULL
67404	NULL
Illkirch	NULL
Cédex	NULL
,	NULL
C.	NULL
U.	NULL
de	NULL
Strasbourg	NULL
,	NULL
France	NULL
and	NULL
the	NULL
Department	NULL
of	NULL
Cell	NULL
Biology	NULL
and	NULL
Genetics	NULL
,	NULL
Medical	NULL
Genetics	NULL
Center	NULL
,	NULL
Erasmus	NULL
University	NULL
,	NULL
P.	NULL
O	NULL
.	NULL

Box	NULL
1738	NULL
,	NULL
3000	NULL
DR	NULL
Roiterdam	NULL
,	NULL
The	NULL
Netherlands	NULL
XPB	NULL
is	NULL
a	NULL
subunit	NULL
of	NULL
the	NULL
basal	NULL
transcription	NULL
factor	NULL
TFIIH	NULL
,	NULL
which	NULL
is	NULL
also	NULL
involved	NULL
in	NULL
nucleotide	NULL
excision	NULL
repair	NULL
(	NULL
NER	NULL
)	NULL
and	NULL
potentially	NULL
in	NULL
cell	NULL
cycle	NULL
regulation	NULL
.	NULL

A	NULL
frameshift	NULL
mutation	NULL
in	NULL
the	NULL
3'-end	NULL
of	NULL
the	NULL
XPB	NULL
gene	NULL
is	NULL
responsible	NULL
for	NULL
a	NULL
concurrence	NULL
of	NULL
two	NULL
disorders	NULL
:	NULL
xeroderma	NULL
pigmentosum	NULL
(	NULL
XP	NULL
)	NULL
and	NULL
Cockayne	NULL
's	NULL
syndrome	NULL
(	NULL
CS	NULL
)	NULL
.	NULL

We	NULL
have	NULL
isolated	NULL
TFIIH	NULL
from	NULL
cells	NULL
derived	NULL
from	NULL
a	NULL
patient	NULL
(	NULL
XP11BE	NULL
)	NULL
who	NULL
carries	NULL
this	NULL
frameshift	NULL
mutation	NULL
(	NULL
TFI-IHmut	NULL
)	NULL
and	NULL
from	NULL
the	NULL
mother	NULL
of	NULL
this	NULL
patient	NULL
(	NULL
TFIIHwt	NULL
)	NULL
to	NULL
determine	NULL
the	NULL
biochemical	NULL
consequences	NULL
of	NULL
the	NULL
mutation	NULL
.	NULL

Although	NULL
identical	NULL
in	NULL
composition	NULL
and	NULL
stoichiometry	NULL
to	NULL
TFIIHwt	NULL
,	NULL
TF	NULL
!	NULL

lHmut	NULL
shows	NULL
a	NULL
reduced	NULL
3	NULL
'	NULL
-	NULL
>	NULL
5	NULL
'	NULL
XPB	NULL
helicase	NULL
activity	NULL
.	NULL

A	NULL
decrease	NULL
in	NULL
helicase	NULL
and	NULL
DNA-dependent	NULL
ATPase	NULL
activities	NULL
was	NULL
also	NULL
observed	NULL
with	NULL
the	NULL
mutated	NULL
recombinant	NULL
XPB	NULL
protein	NULL
.	NULL

The	NULL
XPB	NULL
mutation	NULL
causes	NULL
a	NULL
severe	NULL
NER	NULL
defect	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
we	NULL
provide	NULL
evidence	NULL
for	NULL
a	NULL
decrease	NULL
in	NULL
basal	NULL
transcription	NULL
activity	NULL
in	NULL
vitro	NULL
.	NULL

The	NULL
latter	NULL
defect	NULL
may	NULL
provide	NULL
an	NULL
explanation	NULL
for	NULL
many	NULL
of	NULL
the	NULL
XP	NULL
and	NULL
CS	NULL
symptoms	NULL
that	NULL
are	NULL
difficult	NULL
to	NULL
rationalize	NULL
based	NULL
solely	NULL
on	NULL
an	NULL
NER	NULL
defect	NULL
.	NULL

Thus	NULL
,	NULL
this	NULL
work	NULL
presents	NULL
the	NULL
first	NULL
detailed	NULL
analysis	NULL
of	NULL
a	NULL
naturally	NULL
occurring	NULL
mutation	NULL
in	NULL
a	NULL
basal	NULL
transcription	NULL
factor	NULL
and	NULL
supports	NULL
the	NULL
concept	NULL
that	NULL
the	NULL
combined	NULL
XP/CS	NULL
clinical	NULL
entity	NULL
is	NULL
actually	NULL
the	NULL
result	NULL
of	NULL
a	NULL
combined	NULL
transcription/repair	NULL
deficiency	NULL
.	NULL

TFIIH	NULL
,	NULL
previously	NULL
called	NULL
BTF2	NULL
,	NULL
was	NULL
originally	NULL
defined	NULL
as	NULL
a	NULL
mammalian	NULL
transcription	NULL
factor	NULL
required	NULL
for	NULL
accurate	NULL
transcription	NULL
of	NULL
protein-coding	NULL
genes	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
TFIIA	NULL
,	NULL
TFIIB	NULL
,	NULL
TFIID	NULL
,	NULL
TFIIE	NULL
,	NULL
TFIIF	NULL
,	NULL
and	NULL
RNA	NULL
polymerase	NULL
II	NULL
,	NULL
TFIIH	NULL
participates	NULL
in	NULL
the	NULL
formation	NULL
of	NULL
the	NULL
active	NULL
transcription	NULL
initiation	NULL
complex	NULL
on	NULL
a	NULL
TATA	NULL
box-containing	NULL
minimal	NULL
promoter	NULL
.	NULL

Binding	NULL
of	NULL
TFIID	NULL
to	NULL
the	NULL
TATA	NULL
box	NULL
sequence	NULL
is	NULL
thought	NULL
to	NULL
initiate	NULL
the	NULL
reaction	NULL
,	NULL
while	NULL
TFIIH	NULL
enters	NULL
the	NULL
complex	NULL
late	NULL
during	NULL
its	NULL
assembly	NULL
(	NULL
1-3	NULL
)	NULL
.	NULL

Recently	NULL
,	NULL
this	NULL
factor	NULL
was	NULL
found	NULL
to	NULL
be	NULL
engaged	NULL
in	NULL
one	NULL
of	NULL
the	NULL
main	NULL
DNA	NULL
repair	NULL
pathways	NULL
,	NULL
nucleotide	NULL
excision	NULL
repair	NULL
(	NULL
NER	NULL
)	NULL
(	NULL
4	NULL
)	NULL
.	NULL

It	NULL
is	NULL
also	NULL
interesting	NULL
to	NULL
note	NULL
that	NULL
TFIIH	NULL
*This	NULL
work	NULL
was	NULL
supported	NULL
in	NULL
part	NULL
by	NULL
grants	NULL
from	NULL
INSERM	NULL
and	NULL
CNRS	NULL
,	NULL
Dutch	NULL
Cancer	NULL
Society	NULL
Project	NULL
EUR	NULL
94-763	NULL
,	NULL
Dutch	NULL
Scientific	NULL
Organization	NULL
Section	NULL
Medical	NULL
Sciences	NULL
Project	NULL
501-93	NULL
,	NULL
and	NULL
the	NULL
Foundation	NULL
for	NULL
Chemical	NULL
Research	NULL
in	NULL
the	NULL
Netherlands	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

§	NULL
Supported	NULL
by	NULL
Rotary	NULL
Foundation	NULL
and	NULL
Université	NULL
Louis	NULL
Pasteur	NULL
fellowships	NULL
.	NULL

||	NULL
To	NULL
whom	NULL
correspondence	NULL
should	NULL
be	NULL
addressed	NULL
.	NULL

Tel	NULL
.	NULL

:	NULL
33-88-65-32-47	NULL
;	NULL
Fax	NULL
:	NULL
33-88-65-32-01	NULL
.	NULL
'	NULL

The	NULL
abbreviations	NULL
used	NULL
are	NULL
:	NULL
NER	NULL
,	NULL
nucleotide	NULL
excision	NULL
repair	NULL
;	NULL
XP	NULL
,	NULL
xeroderma	NULL
pigmentosum	NULL
;	NULL
CS	NULL
,	NULL
Cockayne	NULL
's	NULL
syndrome	NULL
;	NULL
TTD	NULL
,	NULL
trichothio-dystrophy	NULL
;	NULL
Ab	NULL
,	NULL
antibody	NULL
;	NULL
CTD	NULL
,	NULL
C-terminal	NULL
domain	NULL
.	NULL

contains	NULL
two	NULL
polypeptides	NULL
,	NULL
Cdk7	NULL
(	NULL
MO15	NULL
)	NULL
and	NULL
cyclin	NULL
H	NULL
,	NULL
that	NULL
were	NULL
shown	NULL
to	NULL
play	NULL
some	NULL
role	NULL
in	NULL
cell	NULL
cycle	NULL
regulation	NULL
(	NULL
5	NULL
)	NULL
.	NULL

Purification	NULL
of	NULL
TFIIH	NULL
to	NULL
homogeneity	NULL
demonstrated	NULL
that	NULL
it	NULL
is	NULL
a	NULL
multisubunit	NULL
protein	NULL
complex	NULL
that	NULL
contains	NULL
between	NULL
five	NULL
and	NULL
nine	NULL
polypeptides	NULL
,	NULL
including	NULL
p89	NULL
(	NULL
XPB-ERCC3	NULL
)	NULL
and	NULL
p80	NULL
(	NULL
XPD-ERCC2	NULL
)	NULL
,	NULL
two	NULL
DNA	NULL
helicases	NULL
with	NULL
opposite	NULL
polarity	NULL
(	NULL
6-8	NULL
)	NULL
and	NULL
with	NULL
DNA-dependent	NULL
ATPase	NULL
activities	NULL
(	NULL
9	NULL
)	NULL
;	NULL
Cdk7	NULL
(	NULL
MO15	NULL
)	NULL
(	NULL
10	NULL
)	NULL
and	NULL
cyclin	NULL
H	NULL
,	NULL
components	NULL
of	NULL
a	NULL
cyclin-dependent	NULL
kinase-activat-ing	NULL
kinase	NULL
(	NULL
11	NULL
)	NULL
;	NULL
p44	NULL
,	NULL
the	NULL
human	NULL
homologue	NULL
of	NULL
yeast	NULL
SSL1	NULL
(	NULL
12	NULL
)	NULL
and	NULL
p34	NULL
,	NULL
which	NULL
possess	NULL
zinc	NULL
fingers	NULL
motifs	NULL
that	NULL
may	NULL
provide	NULL
TFIIH	NULL
with	NULL
a	NULL
DNA	NULL
binding	NULL
function	NULL
(	NULL
13	NULL
)	NULL
.	NULL

We	NULL
(	NULL
14	NULL
)	NULL
and	NULL
others	NULL
(	NULL
15-18	NULL
)	NULL
recently	NULL
demonstrated	NULL
that	NULL
at	NULL
least	NULL
four	NULL
subunits	NULL
,	NULL
p89	NULL
(	NULL
XPB	NULL
)	NULL
,	NULL
p80	NULL
(	NULL
XPD	NULL
)	NULL
,	NULL
p62	NULL
,	NULL
and	NULL
p44	NULL
,	NULL
are	NULL
involved	NULL
in	NULL
NER	NULL
.	NULL

NER	NULL
is	NULL
the	NULL
main	NULL
repair	NULL
system	NULL
for	NULL
the	NULL
elimination	NULL
of	NULL
a	NULL
wide	NULL
range	NULL
of	NULL
structurally	NULL
unrelated	NULL
DNA	NULL
lesions	NULL
,	NULL
including	NULL
UV-induced	NULL
damage	NULL
and	NULL
numerous	NULL
bulky	NULL
adducts	NULL
.	NULL

At	NULL
least	NULL
six	NULL
steps	NULL
are	NULL
thought	NULL
to	NULL
take	NULL
place	NULL
in	NULL
the	NULL
NER	NULL
reaction	NULL
:	NULL
lesion	NULL
recognition	NULL
,	NULL
followed	NULL
by	NULL
template	NULL
demarcation	NULL
(	NULL
including	NULL
local	NULL
melting	NULL
of	NULL
the	NULL
DNA	NULL
around	NULL
the	NULL
damage	NULL
)	NULL
,	NULL
dual	NULL
incision	NULL
of	NULL
the	NULL
injured	NULL
strand	NULL
(	NULL
each	NULL
site	NULL
at	NULL
some	NULL
distance	NULL
from	NULL
the	NULL
lesion	NULL
)	NULL
,	NULL
release	NULL
of	NULL
the	NULL
27-29-nucleotide	NULL
damage-containing	NULL
oligomer	NULL
(	NULL
19	NULL
)	NULL
,	NULL
gap-filling	NULL
DNA	NULL
repair	NULL
synthesis	NULL
,	NULL
and	NULL
finally	NULL
sealing	NULL
of	NULL
the	NULL
remaining	NULL
nick	NULL
(	NULL
20	NULL
)	NULL
.	NULL

The	NULL
NER	NULL
reaction	NULL
has	NULL
two	NULL
modalities	NULL
:	NULL
preferential	NULL
repair	NULL
of	NULL
lesions	NULL
that	NULL
block	NULL
ongoing	NULL
transcription	NULL
(	NULL
transcription-coupled	NULL
repair	NULL
)	NULL
and	NULL
the	NULL
slower	NULL
and	NULL
less	NULL
efficient	NULL
global	NULL
genome	NULL
NER	NULL
subpathway	NULL
.	NULL

TFIIH	NULL
appears	NULL
to	NULL
be	NULL
a	NULL
core	NULL
component	NULL
of	NULL
the	NULL
excision	NULL
process	NULL
implicated	NULL
in	NULL
both	NULL
NER	NULL
modes	NULL
.	NULL

One	NULL
of	NULL
the	NULL
putative	NULL
functions	NULL
of	NULL
the	NULL
complex	NULL
is	NULL
the	NULL
opening	NULL
of	NULL
the	NULL
DNA	NULL
required	NULL
for	NULL
the	NULL
incision	NULL
stage	NULL
of	NULL
the	NULL
NER	NULL
reaction	NULL
.	NULL

Three	NULL
hereditary	NULL
,	NULL
genetically	NULL
heterogeneous	NULL
human	NULL
syndromes	NULL
,	NULL
xeroderma	NULL
pigmentosum	NULL
(	NULL
XP	NULL
)	NULL
,	NULL
Cockayne	NULL
's	NULL
syndrome	NULL
(	NULL
CS	NULL
)	NULL
,	NULL
and	NULL
trichothiodystrophy	NULL
(	NULL
TTD	NULL
)	NULL
,	NULL
have	NULL
been	NULL
recognized	NULL
to	NULL
be	NULL
associated	NULL
with	NULL
mutations	NULL
in	NULL
TFIIH	NULL
subunits	NULL
and	NULL
to	NULL
carry	NULL
defects	NULL
in	NULL
the	NULL
NER	NULL
pathway	NULL
(	NULL
21	NULL
)	NULL
.	NULL

Cell	NULL
hybridization	NULL
studies	NULL
have	NULL
identified	NULL
many	NULL
distinct	NULL
complementation	NULL
groups	NULL
within	NULL
and	NULL
considerable	NULL
overlap	NULL
between	NULL
these	NULL
disorders	NULL
:	NULL
seven	NULL
in	NULL
XP	NULL
(	NULL
XP-A	NULL
to	NULL
XP-G	NULL
,	NULL
three	NULL
of	NULL
which	NULL
also	NULL
harbor	NULL
patients	NULL
with	NULL
combined	NULL
XP	NULL
and	NULL
CS	NULL
(	NULL
XP-B	NULL
,	NULL
XP-D	NULL
,	NULL
and	NULL
XP-G	NULL
)	NULL
)	NULL
,	NULL
two	NULL
in	NULL
the	NULL
classical	NULL
form	NULL
of	NULL
CS	NULL
(	NULL
CS-A	NULL
and	NULL
CS-B	NULL
)	NULL
,	NULL
and	NULL
three	NULL
in	NULL
TTD	NULL
(	NULL
XP-B	NULL
,	NULL
XP-D	NULL
,	NULL
and	NULL
TTD-A	NULL
)	NULL
(	NULL
21	NULL
,	NULL
22	NULL
)	NULL
.	NULL

The	NULL
discovery	NULL
of	NULL
TFIIH	NULL
as	NULL
a	NULL
focal	NULL
point	NULL
for	NULL
the	NULL
regulation	NULL
and	NULL
coordination	NULL
of	NULL
different	NULL
cellular	NULL
events	NULL
has	NULL
aided	NULL
the	NULL
interpretation	NULL
of	NULL
some	NULL
unexplained	NULL
clinical	NULL
symptoms	NULL
associated	NULL
with	NULL
defects	NULL
in	NULL
the	NULL
genes	NULL
for	NULL
some	NULL
of	NULL
the	NULL
TFIIH	NULL
subunits	NULL
.	NULL

This	NULL
is	NULL
well	NULL
illustrated	NULL
by	NULL
the	NULL
case	NULL
of	NULL
the	NULL
XPB	NULL
gene	NULL
encoding	NULL
the	NULL
p89	NULL
subunit	NULL
of	NULL
TFIIH	NULL
.	NULL

XP-B	NULL
is	NULL
a	NULL
very	NULL
rare	NULL
form	NULL
of	NULL
XP	NULL
of	NULL
which	NULL
only	NULL
three	NULL
cases	NULL
have	NULL
been	NULL
described	NULL
;	NULL
two	NULL
display	NULL
a	NULL
combination	NULL
of	NULL
XP	NULL
and	NULL
CS	NULL
syndromes	NULL
,	NULL
and	NULL
the	NULL
third	NULL
mani	NULL
fests	NULL
TTD	NULL
.	NULL

In	NULL
XP/CS	NULL
patient	NULL
XP11BE	NULL
,	NULL
the	NULL
most	NULL
severe	NULL
XP-B	NULL
15898	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
A	NULL
3	NULL
'	NULL
-5	NULL
'	NULL
XPB	NULL
Helicase	NULL
Defect	NULL
in	NULL
TFIIH	NULL
case	NULL
,	NULL
a	NULL
C	NULL
to	NULL
A	NULL
transversion	NULL
in	NULL
the	NULL
last	NULL
intron	NULL
of	NULL
the	NULL
XPB	NULL
gene	NULL
generates	NULL
a	NULL
splice	NULL
mutation	NULL
at	NULL
the	NULL
RNA	NULL
level	NULL
(	NULL
23	NULL
)	NULL
and	NULL
a	NULL
frameshift	NULL
at	NULL
the	NULL
protein	NULL
level	NULL
changing	NULL
the	NULL
last	NULL
41	NULL
amino	NULL
acids	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

This	NULL
patient	NULL
had	NULL
acute	NULL
sun	NULL
sensitivity	NULL
with	NULL
the	NULL
pigmentation	NULL
abnormalities	NULL
characteristic	NULL
of	NULL
XP	NULL
,	NULL
including	NULL
actinic	NULL
keratoses	NULL
and	NULL
several	NULL
cutaneous	NULL
malignancies	NULL
,	NULL
in	NULL
addition	NULL
to	NULL
all	NULL
the	NULL
clinical	NULL
hallmarks	NULL
of	NULL
CS	NULL
such	NULL
as	NULL
developmental	NULL
and	NULL
neurological	NULL
abnormalities	NULL
(	NULL
dwarfism	NULL
,	NULL
microencephaly	NULL
,	NULL
and	NULL
deafness	NULL
)	NULL
and	NULL
impaired	NULL
sexual	NULL
development	NULL
(	NULL
24	NULL
,	NULL
25	NULL
)	NULL
.	NULL

The	NULL
cells	NULL
of	NULL
this	NULL
patient	NULL
have	NULL
a	NULL
severe	NULL
defect	NULL
in	NULL
both	NULL
subpathways	NULL
of	NULL
NER	NULL
,	NULL
with	NULL
repair	NULL
synthesis	NULL
being	NULL
only	NULL
5-10	NULL
%	NULL
of	NULL
the	NULL
activity	NULL
of	NULL
normal	NULL
fibroblasts	NULL
(	NULL
26	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
patient	NULL
's	NULL
mother	NULL
,	NULL
het-erozygous	NULL
for	NULL
the	NULL
causative	NULL
allele	NULL
of	NULL
the	NULL
XPB	NULL
gene	NULL
,	NULL
was	NULL
clinically	NULL
normal	NULL
and	NULL
had	NULL
wild-type	NULL
levels	NULL
of	NULL
DNA	NULL
repair	NULL
consistent	NULL
with	NULL
the	NULL
recessive	NULL
nature	NULL
of	NULL
the	NULL
genetic	NULL
defect	NULL
.	NULL

It	NULL
was	NULL
proposed	NULL
that	NULL
many	NULL
of	NULL
the	NULL
CS	NULL
and	NULL
TTD	NULL
features	NULL
(	NULL
such	NULL
as	NULL
neurodysmyelination	NULL
,	NULL
brittle	NULL
hair	NULL
,	NULL
and	NULL
growth	NULL
defect	NULL
among	NULL
others	NULL
)	NULL
unexplainable	NULL
based	NULL
only	NULL
on	NULL
an	NULL
NER	NULL
defect	NULL
may	NULL
be	NULL
due	NULL
to	NULL
a	NULL
deficiency	NULL
in	NULL
the	NULL
transcription	NULL
function	NULL
of	NULL
TFIIH	NULL
.	NULL

This	NULL
dysfunction	NULL
might	NULL
cause	NULL
a	NULL
reduced	NULL
expression	NULL
of	NULL
a	NULL
specific	NULL
set	NULL
of	NULL
genes	NULL
particularly	NULL
sensitive	NULL
to	NULL
a	NULL
malfunctioning	NULL
TFIIH	NULL
(	NULL
21	NULL
)	NULL
.	NULL

The	NULL
aim	NULL
of	NULL
this	NULL
study	NULL
was	NULL
to	NULL
characterize	NULL
at	NULL
the	NULL
biochemical	NULL
level	NULL
the	NULL
defect	NULL
in	NULL
TFIIH	NULL
that	NULL
is	NULL
responsible	NULL
for	NULL
the	NULL
diverse	NULL
set	NULL
of	NULL
severe	NULL
clinical	NULL
features	NULL
.	NULL

We	NULL
have	NULL
analyzed	NULL
the	NULL
enzymatic	NULL
activities	NULL
of	NULL
TFIIH	NULL
isolated	NULL
from	NULL
the	NULL
lymphoblasts	NULL
of	NULL
XP11BE	NULL
.	NULL

Our	NULL
results	NULL
show	NULL
that	NULL
the	NULL
mutated	NULL
XPB	NULL
polypeptide	NULL
associated	NULL
with	NULL
TFIIH	NULL
presents	NULL
both	NULL
helicase	NULL
and	NULL
ATPase	NULL
deficiencies	NULL
that	NULL
directly	NULL
or	NULL
indirectly	NULL
impair	NULL
the	NULL
NER	NULL
reaction	NULL
and	NULL
,	NULL
to	NULL
a	NULL
lesser	NULL
extent	NULL
,	NULL
appear	NULL
also	NULL
to	NULL
affect	NULL
basal	NULL
transcription	NULL
.	NULL

These	NULL
results	NULL
provide	NULL
an	NULL
explanation	NULL
for	NULL
the	NULL
large	NULL
range	NULL
of	NULL
clinical	NULL
symptoms	NULL
associated	NULL
with	NULL
CS	NULL
and	NULL
TTD	NULL
,	NULL
some	NULL
of	NULL
which	NULL
are	NULL
unrelated	NULL
to	NULL
an	NULL
NER	NULL
deficiency	NULL
.	NULL

EXPERIMENTAL	NULL
PROCEDURES	NULL
Purification	NULL
of	NULL
TFllHmut	NULL
and	NULL
TFIIHwt-Extracts	NULL
were	NULL
prepared	NULL
with	NULL
80	NULL
liters	NULL
(	NULL
0.7	NULL
X	NULL
10°	NULL
cells/ml	NULL
)	NULL
of	NULL
either	NULL
GM2252A	NULL
cells	NULL
(	NULL
lymphoblas-toid	NULL
cell	NULL
line	NULL
derived	NULL
from	NULL
an	NULL
XP-B	NULL
patient	NULL
)	NULL
or	NULL
GM1855	NULL
cells	NULL
(	NULL
lympho-blastoid	NULL
cell	NULL
line	NULL
derived	NULL
from	NULL
the	NULL
patient	NULL
's	NULL
mother	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
grown	NULL
in	NULL
suspension	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
(	NULL
Life	NULL
Technologies	NULL
,	NULL
Inc.	NULL
)	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
and	NULL
40	NULL
pg/ml	NULL
gentamicin	NULL
and	NULL
collected	NULL
by	NULL
centrifugation	NULL
for	NULL
a	NULL
whole	NULL
cell	NULL
extract	NULL
preparation	NULL
.	NULL

TFIIH	NULL
purification	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
30	NULL
)	NULL
,	NULL
except	NULL
for	NULL
the	NULL
fourth	NULL
purification	NULL
step	NULL
,	NULL
which	NULL
used	NULL
a	NULL
TSK-heparin-5PW	NULL
column	NULL
(	NULL
0.75	NULL
xX	NULL
7.5	NULL
em	NULL
,	NULL
flow	NULL
rate	NULL
of	NULL
0.6	NULL
ml/min	NULL
;	NULL
Toso-Haas	NULL
,	NULL
Stuttgart	NULL
,	NULL
Germany	NULL
)	NULL
.	NULL

The	NULL
transcriptionally	NULL
active	NULL
fractions	NULL
of	NULL
SP-5PW	NULL
preparations	NULL
(	NULL
300	NULL
ml	NULL
,	NULL
eluted	NULL
at	NULL
0.45	NULL
M	NULL
KCI	NULL
)	NULL
were	NULL
pooled	NULL
and	NULL
dialyzed	NULL
against	NULL
50	NULL
mM	NULL
Tris-HCl	NULL
,	NULL
pH	NULL
7.6	NULL
,	NULL
50	NULL
mm	NULL
KCl	NULL
,	NULL
0.5	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
0.1	NULL
mM	NULL
EDTA	NULL
,	NULL
and	NULL
10	NULL
%	NULL
glycerol	NULL
before	NULL
being	NULL
loaded	NULL
onto	NULL
the	NULL
heparin-5PW	NULL
column	NULL
equilibrated	NULL
in	NULL
the	NULL
same	NULL
buffer	NULL
.	NULL

The	NULL
TFIIH	NULL
fraction	NULL
was	NULL
eluted	NULL
with	NULL
a	NULL
20-ml	NULL
linear	NULL
gradient	NULL
from	NULL
0	NULL
to	NULL
0.9	NULL
M	NULL
ammonium	NULL
sulfate	NULL
and	NULL
tested	NULL
repeatedly	NULL
in	NULL
in	NULL
vitro	NULL
transcription	NULL
(	NULL
28	NULL
)	NULL
,	NULL
helicase	NULL
,	NULL
CTD	NULL
kinase	NULL
,	NULL
and	NULL
DNA-dependent	NULL
ATPase	NULL
(	NULL
29	NULL
)	NULL
assays	NULL
.	NULL

For	NULL
each	NULL
TFIIH	NULL
,	NULL
three	NULL
different	NULL
preparations	NULL
were	NULL
performed	NULL
.	NULL

Bidirectional	NULL
Helicase	NULL
Assay-To	NULL
prepare	NULL
helicase	NULL
substrate	NULL
,	NULL
5	NULL
ng	NULL
of	NULL
an	NULL
oligonucleotide	NULL
corresponding	NULL
to	NULL
fragment	NULL
6219-6255	NULL
of	NULL
single-stranded	NULL
M13mp18	NULL
(	NULL
-	NULL
)	NULL
DNA	NULL
was	NULL
annealed	NULL
to	NULL
1	NULL
ug	NULL
of	NULL
single-stranded	NULL
M13mp18	NULL
DNA	NULL
in	NULL
5	NULL
mm	NULL
Tris-HCl	NULL
,	NULL
pH	NULL
7.9	NULL
,	NULL
25	NULL
mM	NULL
NaCl	NULL
,	NULL
and	NULL
2.5	NULL
mM	NULL
MgC	NULL
]	NULL
,	NULL
by	NULL
incubation	NULL
at	NULL
95	NULL
°C	NULL
for	NULL
5	NULL
min	NULL
followed	NULL
by	NULL
30	NULL
min	NULL
at	NULL
24	NULL
°C	NULL
.	NULL

The	NULL
resulting	NULL
heteroduplex	NULL
was	NULL
digested	NULL
for	NULL
1	NULL
h	NULL
at	NULL
37	NULL
°C	NULL
with	NULL
EcoRI	NULL
(	NULL
New	NULL
England	NULL
Biolabs	NULL
Inc.	NULL
)	NULL
,	NULL
thus	NULL
generating	NULL
two	NULL
duplex	NULL
regions	NULL
of	NULL
17	NULL
and	NULL
20	NULL
base	NULL
pairs	NULL
.	NULL

The	NULL
oligonucleotide	NULL
was	NULL
then	NULL
elongated	NULL
with	NULL
DNA	NULL
polymerase	NULL
I	NULL
Klenow	NULL
fragment	NULL
(	NULL
5	NULL
units	NULL
)	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
50	NULL
um	NULL
TTP	NULL
,	NULL
30	NULL
uM	NULL
dGTP	NULL
,	NULL
7	NULL
1Ci	NULL
of	NULL
[	NULL
a-	NULL
``	NULL
``	NULL
P	NULL
]	NULL
dATP	NULL
(	NULL
3000	NULL
Ci/mmol	NULL
)	NULL
(	NULL
Amersham	NULL
International	NULL
,	NULL
Buckinghamshire	NULL
,	NULL
United	NULL
Kingdom	NULL
)	NULL
,	NULL
and	NULL
4	NULL
mM	NULL
MgCl	NULL
,	NULL
.	NULL

After	NULL
20	NULL
min	NULL
at	NULL
23	NULL
°C	NULL
,	NULL
50	NULL
um	NULL
dATP	NULL
was	NULL
added	NULL
to	NULL
the	NULL
reaction	NULL
mixture	NULL
,	NULL
which	NULL
was	NULL
then	NULL
incubated	NULL
for	NULL
another	NULL
20	NULL
min	NULL
at	NULL
23	NULL
°C	NULL
.	NULL

After	NULL
phenol/chloroform	NULL
extrac-tion	NULL
,	NULL
the	NULL
free	NULL
nucleotides	NULL
were	NULL
removed	NULL
by	NULL
gel	NULL
filtration	NULL
on	NULL
Sephadex	NULL
G-50	NULL
(	NULL
Pharmacia	NULL
,	NULL
Uppsala	NULL
)	NULL
.	NULL

The	NULL
DNA	NULL
helicase	NULL
assay	NULL
(	NULL
25	NULL
l	NULL
)	NULL
contained	NULL
20	NULL
mm	NULL
Tris-HCl	NULL
,	NULL
pH	NULL
7.9	NULL
,	NULL
4	NULL
mm	NULL
MgCl	NULL
,	NULL
,	NULL
1	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
50	NULL
ug/ml	NULL
bovine	NULL
serum	NULL
albumin	NULL
,	NULL
2	NULL
mM	NULL
ATP	NULL
,	NULL
and	NULL
1-3	NULL
ng	NULL
of	NULL
DNA	NULL
substrate	NULL
.	NULL

Reactions	NULL
were	NULL
incubated	NULL
at	NULL
37	NULL
°C	NULL
for	NULL
45	NULL
min	NULL
;	NULL
stopped	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
10	NULL
ul	NULL
of	NULL
60	NULL
mM	NULL
EDTA	NULL
,	NULL
50	NULL
%	NULL
glycerol	NULL
,	NULL
0.75	NULL
%	NULL
SDS	NULL
,	NULL
and	NULL
0.1	NULL
%	NULL
bromphe-	NULL
15899	NULL
nol	NULL
blue	NULL
;	NULL
and	NULL
loaded	NULL
on	NULL
a	NULL
10	NULL
%	NULL
nondenaturing	NULL
acrylamide	NULL
gel	NULL
in	NULL
0.5	NULL
x	NULL
Tris-borate/EDTA	NULL
buffer	NULL
,	NULL
pH	NULL
8	NULL
,	NULL
at	NULL
100-200	NULL
V.	NULL
The	NULL
gel	NULL
was	NULL
then	NULL
dried	NULL
and	NULL
analyzed	NULL
by	NULL
autoradiography	NULL
.	NULL

The	NULL
substrate	NULL
heated	NULL
for	NULL
2	NULL
min	NULL
at	NULL
100	NULL
°C	NULL
was	NULL
used	NULL
as	NULL
positive	NULL
control	NULL
.	NULL

Immunoprecipitation-The	NULL
monoclonal	NULL
antibodies	NULL
to	NULL
p62	NULL
and	NULL
Cdk7	NULL
(	NULL
MO15	NULL
)	NULL
were	NULL
cross-linked	NULL
to	NULL
protein	NULL
A-agarose	NULL
.	NULL

The	NULL
TFIlHmut-	NULL
and	NULL
TFIIHwt-heparin-5PW	NULL
fractions	NULL
were	NULL
incubated	NULL
for	NULL
1	NULL
h	NULL
at	NULL
4	NULL
°C	NULL
with	NULL
the	NULL
antibodies	NULL
in	NULL
buffer	NULL
A	NULL
(	NULL
50	NULL
mM	NULL
Tris-HCl	NULL
,	NULL
pH	NULL
7.9	NULL
,	NULL
10	NULL
%	NULL
glycerol	NULL
,	NULL
0.1	NULL
mM	NULL
EDTA	NULL
,	NULL
and	NULL
150	NULL
mM	NULL
KCl	NULL
)	NULL
containing	NULL
1	NULL
mg/ml	NULL
bovine	NULL
serum	NULL
albumin	NULL
.	NULL

The	NULL
immunoadsorbed	NULL
complexes	NULL
were	NULL
sequentially	NULL
washed	NULL
three	NULL
times	NULL
with	NULL
buffer	NULL
A	NULL
containing	NULL
0.1	NULL
%	NULL
Nonidet	NULL
P-40	NULL
and	NULL
twice	NULL
with	NULL
buffer	NULL
A	NULL
containing	NULL
0.1	NULL
%	NULL
Nonidet	NULL
P-40	NULL
and	NULL
0.5	NULL
m	NULL
KC	NULL
]	NULL
and	NULL
equilibrated	NULL
in	NULL
50	NULL
mM	NULL
Tris-HCl	NULL
,	NULL
pH	NULL
7.9	NULL
,	NULL
containing	NULL
10	NULL
%	NULL
glycerol	NULL
,	NULL
0.1	NULL
mM	NULL
EDTA	NULL
,	NULL
and	NULL
50	NULL
mM	NULL
KCl	NULL
before	NULL
being	NULL
tested	NULL
in	NULL
the	NULL
bidirectional	NULL
helicase	NULL
assay	NULL
.	NULL

Preparation	NULL
of	NULL
Mutated	NULL
Recombinant	NULL
XPB-The	NULL
XL-1	NULL
blue	NULL
strain	NULL
of	NULL
Escherichia	NULL
coli	NULL
transformed	NULL
with	NULL
pSK	NULL
(	NULL
-	NULL
)	NULL
was	NULL
used	NULL
to	NULL
generate	NULL
a	NULL
single-stranded	NULL
DNA	NULL
template	NULL
.	NULL

The	NULL
XL-1	NULL
blue	NULL
cells	NULL
containing	NULL
XPBwt	NULL
in	NULL
pSK	NULL
(	NULL
-	NULL
)	NULL
were	NULL
grown	NULL
with	NULL
M13	NULL
phage	NULL
at	NULL
37°C	NULL
in	NULL
2	NULL
x	NULL
YT	NULL
medium	NULL
supplemented	NULL
with	NULL
75	NULL
ug/ml	NULL
ampicillin	NULL
and	NULL
12	NULL
ug/ml	NULL
tetracycline	NULL
for	NULL
1-2	NULL
h.	NULL
Kanamycin	NULL
was	NULL
added	NULL
to	NULL
a	NULL
final	NULL
concentration	NULL
of	NULL
70	NULL
ug/ml	NULL
,	NULL
and	NULL
the	NULL
culture	NULL
was	NULL
shaken	NULL
for	NULL
16-24	NULL
h	NULL
or	NULL
until	NULL
growth	NULL
had	NULL
reached	NULL
satu-ration	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
spun	NULL
down	NULL
for	NULL
5	NULL
min	NULL
,	NULL
and	NULL
0.1	NULL
volume	NULL
of	NULL
20	NULL
%	NULL
polyethylene	NULL
glycol	NULL
,	NULL
2.5	NULL
M	NULL
NaCl	NULL
was	NULL
added	NULL
to	NULL
the	NULL
supernatant	NULL
.	NULL

After	NULL
a	NULL
15-min	NULL
incubation	NULL
on	NULL
ice	NULL
,	NULL
the	NULL
supernatant	NULL
was	NULL
removed	NULL
by	NULL
centrifugation	NULL
,	NULL
and	NULL
the	NULL
pellet	NULL
was	NULL
resuspended	NULL
in	NULL
0.3	NULL
M	NULL
NaOAc	NULL
,	NULL
pH	NULL
6.0	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
.	NULL

The	NULL
DNA	NULL
was	NULL
phenol/chloroform-extracted	NULL
,	NULL
ethanol-precipi-tated	NULL
,	NULL
and	NULL
resuspended	NULL
in	NULL
10	NULL
mm	NULL
Tris-HCl	NULL
,	NULL
pH	NULL
7.6	NULL
,	NULL
1	NULL
mm	NULL
EDTA	NULL
.	NULL

The	NULL
mutated	NULL
oligonucleotide	NULL
(	NULL
5'-AGCCAGGCCGGCATCTCGGC-3	NULL
'	NULL
)	NULL
was	NULL
phosphorylated	NULL
at	NULL
the	NULL
5'-end	NULL
with	NULL
10	NULL
units	NULL
of	NULL
bacteriophage	NULL
T4	NULL
polynucleotide	NULL
kinase	NULL
(	NULL
30	NULL
min	NULL
at	NULL
37	NULL
°C	NULL
and	NULL
then	NULL
5	NULL
min	NULL
at	NULL
65	NULL
°C	NULL
)	NULL
and	NULL
was	NULL
annealed	NULL
with	NULL
the	NULL
single-stranded	NULL
XPB	NULL
template	NULL
by	NULL
a	NULL
5-min	NULL
incubation	NULL
at	NULL
65	NULL
°C	NULL
and	NULL
then	NULL
slow	NULL
cooling	NULL
to	NULL
room	NULL
temperature	NULL
in	NULL
5	NULL
ul	NULL
of	NULL
16	NULL
mx	NULL
Tris-HCl	NULL
,	NULL
pH	NULL
7.5	NULL
,	NULL
200	NULL
mM	NULL
NaCl	NULL
,	NULL
and	NULL
80	NULL
mm	NULL
MgCl	NULL
,	NULL
.	NULL

Second	NULL
strand	NULL
synthesis	NULL
was	NULL
continued	NULL
in	NULL
a	NULL
15-Ll	NULL
reaction	NULL
mixture	NULL
of	NULL
20	NULL
mM	NULL
Tris-HCl	NULL
,	NULL
pH	NULL
7.5	NULL
,	NULL
10	NULL
mm	NULL
MgCl	NULL
,	NULL
,	NULL
5	NULL
my	NULL
dithiothreitol	NULL
,	NULL
0.7	NULL
mM	NULL
ATP	NULL
,	NULL
0.7	NULL
mm	NULL
dNTPs	NULL
,	NULL
3	NULL
units	NULL
of	NULL
T4	NULL
DNA	NULL
polymerase	NULL
,	NULL
and	NULL
6	NULL
Weiss	NULL
units	NULL
of	NULL
T4	NULL
ligase	NULL
(	NULL
New	NULL
England	NULL
Biolabs	NULL
Inc.	NULL
)	NULL
for	NULL
3	NULL
h.	NULL
After	NULL
ligation	NULL
and	NULL
transformation	NULL
into	NULL
competent	NULL
Mut.L	NULL
cells	NULL
,	NULL
plasmids	NULL
isolated	NULL
from	NULL
randomly	NULL
picked	NULL
colonies	NULL
were	NULL
sequenced	NULL
.	NULL

Overexpression	NULL
of	NULL
Wild-type	NULL
and	NULL
Mutated	NULL
Recombinant	NULL
XPB	NULL
Pro-teins-E.	NULL
coli	NULL
strain	NULL
BL21	NULL
(	NULL
DE3	NULL
)	NULL
containing	NULL
the	NULL
wild-type	NULL
or	NULL
mutated	NULL
pGEX2TK-p89	NULL
plasmid	NULL
was	NULL
grown	NULL
in	NULL
LB	NULL
medium	NULL
supplemented	NULL
with	NULL
ampicillin	NULL
(	NULL
50	NULL
ug/ml	NULL
!	NULL
)	NULL

at	NULL
37	NULL
°C	NULL
.	NULL

Expression	NULL
was	NULL
induced	NULL
with	NULL
isopropyl-1-thio-B-D-galactopyranoside	NULL
(	NULL
0.4	NULL
mM	NULL
)	NULL
at	NULL
an	NULL
absorbance	NULL
of	NULL
0.6	NULL
at	NULL
600	NULL
nm	NULL
.	NULL

After	NULL
3	NULL
h	NULL
at	NULL
37	NULL
°C	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
collected	NULL
by	NULL
centrifugation	NULL
,	NULL
and	NULL
the	NULL
pellet	NULL
was	NULL
resuspended	NULL
in	NULL
50	NULL
mm	NULL
Tris-HCl	NULL
,	NULL
pH	NULL
7.5	NULL
,	NULL
150	NULL
mm	NULL
NaCl	NULL
,	NULL
and	NULL
0.5	NULL
%	NULL
Triton	NULL
X-100	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
frozen	NULL
,	NULL
thawed	NULL
,	NULL
and	NULL
lysed	NULL
by	NULL
sonication	NULL
on	NULL
ice	NULL
.	NULL

After	NULL
centrifugation	NULL
for	NULL
10	NULL
min	NULL
at	NULL
15,000	NULL
rpm	NULL
in	NULL
an	NULL
R45Ti	NULL
rotor	NULL
,	NULL
the	NULL
soluble	NULL
fractions	NULL
were	NULL
collected	NULL
,	NULL
and	NULL
the	NULL
pellets	NULL
were	NULL
resuspended	NULL
in	NULL
the	NULL
same	NULL
buffer	NULL
as	NULL
described	NULL
above	NULL
.	NULL

Wild-type	NULL
or	NULL
mutated	NULL
recombinant	NULL
XPB	NULL
was	NULL
purified	NULL
with	NULL
a	NULL
glutathione	NULL
S-transferase	NULL
affinity	NULL
column	NULL
(	NULL
Pharmacia	NULL
)	NULL
.	NULL

All	NULL
fractions	NULL
were	NULL
frozen	NULL
in	NULL
liquid	NULL
nitrogen	NULL
and	NULL
stored	NULL
at	NULL
-80	NULL
°C	NULL
.	NULL

Production	NULL
of	NULL
Antibodies-Ab-CTmut	NULL
is	NULL
a	NULL
monoclonal	NULL
antibody	NULL
raised	NULL
against	NULL
the	NULL
483	NULL
C-terminal	NULL
amino	NULL
acids	NULL
of	NULL
XPBmut	NULL
:	NULL
QAGISAL-WHHEFYVWGRRHCVHGVPLIAEQGAQQTCTPALQAL	NULL
.	NULL

The	NULL
anti-XPBwt	NULL
and	NULL
anti-p80	NULL
(	NULL
7	NULL
)	NULL
,	NULL
anti-p62	NULL
(	NULL
87	NULL
)	NULL
,	NULL
anti-p44	NULL
and	NULL
anti-p34	NULL
(	NULL
13	NULL
)	NULL
,	NULL
and	NULL
anti-MO15	NULL
(	NULL
88	NULL
)	NULL
antibodies	NULL
were	NULL
as	NULL
described	NULL
.	NULL

RESULTS	NULL
Purification	NULL
and	NULL
Characterization	NULL
of	NULL
TFIIH-To	NULL
assess	NULL
the	NULL
effects	NULL
of	NULL
the	NULL
frameshift	NULL
mutation	NULL
in	NULL
XPB	NULL
on	NULL
the	NULL
various	NULL
enzymatic	NULL
activities	NULL
associated	NULL
with	NULL
TFIIH	NULL
,	NULL
extracts	NULL
(	NULL
27	NULL
)	NULL
prepared	NULL
from	NULL
lymphoblastoid	NULL
cells	NULL
derived	NULL
from	NULL
either	NULL
the	NULL
XP-B	NULL
patient	NULL
(	NULL
XP11BE	NULL
)	NULL
or	NULL
her	NULL
mother	NULL
(	NULL
as	NULL
a	NULL
control	NULL
)	NULL
were	NULL
subjected	NULL
to	NULL
several	NULL
chromatographic	NULL
steps	NULL
of	NULL
the	NULL
TFIIH	NULL
purification	NULL
scheme	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
;	NULL
see	NULL
``	NULL
Experimental	NULL
Procedures	NULL
``	NULL
)	NULL
.	NULL

Using	NULL
a	NULL
monoclonal	NULL
antibody	NULL
directed	NULL
against	NULL
the	NULL
recombinant	NULL
XPB	NULL
protein	NULL
,	NULL
we	NULL
showed	NULL
that	NULL
this	NULL
polypeptide	NULL
is	NULL
present	NULL
in	NULL
both	NULL
cell	NULL
lines	NULL
and	NULL
possesses	NULL
the	NULL
predicted	NULL
molecular	NULL
weight	NULL
(	NULL
Fig	NULL
.	NULL

1C	NULL
)	NULL
.	NULL

An	NULL
antibody	NULL
raised	NULL
against	NULL
an	NULL
oligopeptide	NULL
corresponding	NULL
to	NULL
the	NULL
frameshifted	NULL
carboxyl	NULL
terminus	NULL
of	NULL
the	NULL
mutated	NULL
XPB	NULL
polypeptide	NULL
of	NULL
XP11BE	NULL
(	NULL
Ab-CTmut	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
revealed	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
mutant	NULL
XPB	NULL
gene	NULL
product	NULL
in	NULL
the	NULL
TFIIH	NULL
fraction	NULL
derived	NULL
from	NULL
the	NULL
patient	NULL
's	NULL
cell	NULL
line	NULL
(	NULL
TF	NULL
!	NULL

lHmut	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

1C	NULL
,	NULL
lane	NULL
9	NULL
)	NULL
.	NULL

The	NULL
mutated	NULL
XPB	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
15900	NULL
A	NULL
3	NULL
``	NULL
-5	NULL
'	NULL
XPB	NULL
Helicase	NULL
Defect	NULL
in	NULL
TFIIH	NULL
WCE	NULL
B	NULL
GM2252A	NULL
:	NULL
TFilH	NULL
(	NULL
mut	NULL
)	NULL
Ab-CTwt	NULL
GM1855	NULL
:	NULL
TFIIH	NULL
(	NULL
wt	NULL
)	NULL
NH	NULL
U	NULL
5	NULL
:	NULL
XPB	NULL
wh	NULL
ir-	NULL
-in	NULL
-w	NULL
y	NULL
--	NULL
}	NULL
-	NULL
NLS	NULL
-	NULL
DNA-BD	NULL
a	NULL
Heparin	NULL
-	NULL
Ultrogel	NULL
XPB	NULL
mut	NULL
-	NULL
oic	NULL
nt	NULL
»	NULL
``	NULL
XPB	NULL
75	NULL
;	NULL
--	NULL
--	NULL
-	NULL
4	NULL
FT	NULL
0.22	NULL
0.40	NULL
1M	NULL
KCl	NULL
Tig	NULL
Ab-CTmut	NULL
iDEAE	NULL
XPB	NULL
wt	NULL
pul	NULL
.	NULL

R—SfoQn	NULL
‘	NULL
la	NULL
.l	NULL
!	NULL

-	NULL
epnerodex	NULL
XPB	NULL
mut	NULL
.	NULL

FT	NULL
0.20	NULL
0.95	NULL
1M	NULL
KCI	NULL
C	NULL
Sulfopropyt	NULL
-	NULL
SPW	NULL
Fi	NULL
0.28	NULL
0.45	NULL
1M	NULL
KCI	NULL
Heparin	NULL
-	NULL
SPW	NULL
g	NULL
--	NULL
--	NULL
-*	NULL
0.9	NULL
M	NULL
AS	NULL
0.49	NULL
,	NULL
TFIH	NULL
Ab-CTmut	NULL
HOM	NULL
OP	NULL
OH	NULL
OM	NULL
OPO	NULL
HOMOP	NULL
\	NULL
as	NULL
-	NULL
<	NULL
-	NULL
pBY/XPB	NULL
wee	NULL
whi	NULL
me	NULL
4	NULL
r	NULL
«	NULL
-	NULL
p62	NULL
an	NULL
am	NULL
om	NULL
.	NULL

mpl	NULL
lae	NULL
«	NULL
-	NULL
p44	NULL
wa	NULL
tat	NULL
|	NULL
a	NULL
._	NULL
...	NULL
,	NULL
‘	NULL
.	NULL

*	NULL
.	NULL
'	NULL

.	NULL

“	NULL
Rina—p34	NULL
1	NULL
2	NULL
3	NULL
4	NULL
50	NULL
60	NULL
7T	NULL
a	NULL
9	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

A	NULL
,	NULL
purification	NULL
scheme	NULL
of	NULL
TFIlHmut	NULL
and	NULL
TFIIHwt	NULL
from	NULL
GM2252A	NULL
and	NULL
GM1855	NULL
lymphoblast	NULL
cells	NULL
,	NULL
respectively	NULL
.	NULL

WCE	NULL
,	NULL
whole	NULL
cell	NULL
extract	NULL
.	NULL

The	NULL
salt	NULL
concentration	NULL
at	NULL
which	NULL
TFIIHmut	NULL
and	NULL
TFIIHwt	NULL
were	NULL
eluted	NULL
from	NULL
the	NULL
various	NULL
columns	NULL
is	NULL
underlined	NULL
.	NULL

B	NULL
,	NULL
schematic	NULL
diagram	NULL
of	NULL
the	NULL
wild-type	NULL
and	NULL
mutated	NULL
XPB	NULL
polypeptides	NULL
.	NULL

The	NULL
putative	NULL
character	NULL
of	NULL
the	NULL
domains	NULL
is	NULL
indicated	NULL
:	NULL
the	NULL
seven	NULL
conserved	NULL
helicase	NULL
domains	NULL
are	NULL
marked	NULL
by	NULL
solid	NULL
boxes	NULL
numbered	NULL
from	NULL
I	NULL
to	NULL
VZ	NULL
;	NULL
the	NULL
nuclear	NULL
localization	NULL
signal	NULL
(	NULL
NLS	NULL
)	NULL
and	NULL
the	NULL
DNA-binding	NULL
domain	NULL
(	NULL
DNA-BD	NULL
)	NULL
are	NULL
designated	NULL
(	NULL
see	NULL
Refs	NULL
.	NULL

23	NULL
and	NULL
31	NULL
)	NULL
.	NULL

The	NULL
peptides	NULL
used	NULL
to	NULL
induce	NULL
the	NULL
antibodies	NULL
raised	NULL
against	NULL
either	NULL
the	NULL
wild-type	NULL
(	NULL
Ab-CT'wt	NULL
)	NULL
or	NULL
the	NULL
mutated	NULL
(	NULL
Ab-CT'mut	NULL
)	NULL
C-terminal	NULL
domain	NULL
of	NULL
XPB	NULL
are	NULL
indicated	NULL
on	NULL
the	NULL
sequence	NULL
(	NULL
arrows	NULL
)	NULL
.	NULL

C	NULL
,	NULL
immunoblot	NULL
analysis	NULL
of	NULL
TFIIH	NULL
(	NULL
heparin-5PW	NULL
fraction	NULL
)	NULL
prepared	NULL
from	NULL
HeLa	NULL
(	NULL
)	NULL
,	NULL
GM1855	NULL
(	NULL
mother	NULL
(	NULL
M	NULL
)	NULL
)	NULL
,	NULL
and	NULL
GM2252A	NULL
(	NULL
patient	NULL
(	NULL
P	NULL
)	NULL
)	NULL
cells	NULL
using	NULL
antibodies	NULL
against	NULL
the	NULL
recombinant	NULL
XPB	NULL
(	NULL
Ab-XPB	NULL
)	NULL
,	NULL
wild-type	NULL
(	NULL
Ab-CT'wt	NULL
)	NULL
,	NULL
or	NULL
mutated	NULL
(	NULL
Ab-CTmut	NULL
)	NULL
XPB	NULL
C-terminal	NULL
oligopeptides	NULL
.	NULL

The	NULL
arrows	NULL
indicate	NULL
the	NULL
four	NULL
subunits	NULL
of	NULL
TFIIH	NULL
.	NULL

polypeptide	NULL
was	NULL
also	NULL
present	NULL
,	NULL
although	NULL
in	NULL
lower	NULL
amounts	NULL
(	NULL
10-15	NULL
%	NULL
of	NULL
the	NULL
amount	NULL
found	NULL
in	NULL
the	NULL
patient	NULL
)	NULL
,	NULL
in	NULL
TFIIH	NULL
prepared	NULL
from	NULL
the	NULL
cell	NULL
line	NULL
of	NULL
the	NULL
mother	NULL
(	NULL
TFIIHwt	NULL
)	NULL
(	NULL
Zane	NULL
8	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
an	NULL
antibody	NULL
generated	NULL
against	NULL
the	NULL
wild-type	NULL
carboxyl	NULL
terminus	NULL
allowed	NULL
us	NULL
to	NULL
detect	NULL
wild-type	NULL
XPB	NULL
in	NULL
the	NULL
cells	NULL
derived	NULL
from	NULL
the	NULL
mother	NULL
(	NULL
Zane	NULL
5	NULL
)	NULL
,	NULL
whereas	NULL
this	NULL
form	NULL
was	NULL
not	NULL
detected	NULL
in	NULL
the	NULL
patient	NULL
's	NULL
cells	NULL
(	NULL
Zane	NULL
6	NULL
)	NULL
.	NULL

This	NULL
is	NULL
consistent	NULL
with	NULL
the	NULL
observation	NULL
that	NULL
the	NULL
paternal	NULL
allele	NULL
is	NULL
not	NULL
detectable	NULL
at	NULL
the	NULL
RNA	NULL
level	NULL
in	NULL
the	NULL
patient	NULL
and	NULL
that	NULL
the	NULL
maternal	NULL
allele	NULL
is	NULL
responsible	NULL
for	NULL
the	NULL
clinical	NULL
phenotype	NULL
(	NULL
23	NULL
)	NULL
.	NULL

The	NULL
purification	NULL
of	NULL
both	NULL
TFIIHwt	NULL
and	NULL
TFIIHmut	NULL
was	NULL
done	NULL
in	NULL
parallel	NULL
under	NULL
the	NULL
same	NULL
conditions	NULL
to	NULL
obtain	NULL
similar	NULL
preparations	NULL
and	NULL
were	NULL
monitored	NULL
using	NULL
the	NULL
following	NULL
enzymatic	NULL
as-says	NULL
:	NULL
a	NULL
reconstituted	NULL
in	NULL
vitro	NULL
transcription	NULL
assay	NULL
lacking	NULL
TFIIH	NULL
(	NULL
28	NULL
)	NULL
,	NULL
a	NULL
kinase	NULL
assay	NULL
(	NULL
29	NULL
)	NULL
,	NULL
a	NULL
bidirectional	NULL
helicase	NULL
assay	NULL
(	NULL
7	NULL
)	NULL
,	NULL
and	NULL
a	NULL
DNA-dependent	NULL
ATPase	NULL
assay	NULL
(	NULL
29	NULL
)	NULL
.	NULL

As	NULL
expected	NULL
from	NULL
previous	NULL
results	NULL
using	NULL
Hela	NULL
extracts	NULL
(	NULL
30	NULL
)	NULL
,	NULL
none	NULL
of	NULL
the	NULL
enzymatic	NULL
activities	NULL
were	NULL
detectable	NULL
during	NULL
the	NULL
first	NULL
two	NULL
steps	NULL
of	NULL
the	NULL
TFIIH	NULL
purification	NULL
.	NULL

For	NULL
adequate	NULL
quantitation	NULL
of	NULL
the	NULL
assays	NULL
and	NULL
further	NULL
comparison	NULL
between	NULL
TFIIHwt	NULL
and	NULL
antibodies	NULL
directed	NULL
against	NULL
either	NULL
the	NULL
p62	NULL
or	NULL
XPB	NULL
subunit	NULL
were	NULL
used	NULL
;	NULL
this	NULL
allowed	NULL
us	NULL
to	NULL
follow	NULL
TFIIH	NULL
during	NULL
the	NULL
purification	NULL
and	NULL
to	NULL
measure	NULL
quantitatively	NULL
the	NULL
relative	NULL
amount	NULL
of	NULL
the	NULL
XPB	NULL
subunit	NULL
present	NULL
in	NULL
each	NULL
fraction	NULL
.	NULL

As	NULL
previously	NULL
shown	NULL
,	NULL
the	NULL
transcription	NULL
,	NULL
CTD	NULL
kinase	NULL
,	NULL
helicase	NULL
,	NULL
and	NULL
DNA-dependent	NULL
ATPase	NULL
activities	NULL
match	NULL
the	NULL
elution	NULL
of	NULL
the	NULL
p62	NULL
and	NULL
XPB	NULL
TFIIH	NULL
subunits	NULL
during	NULL
the	NULL
last	NULL
steps	NULL
of	NULL
the	NULL
purification	NULL
procedure	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Starting	NULL
with	NULL
80	NULL
liters	NULL
of	NULL
lymphoblast	NULL
cells	NULL
(	NULL
0.7	NULL
x	NULL
10°	NULL
cells/ml	NULL
)	NULL
and	NULL
after	NULL
four	NULL
purification	NULL
steps	NULL
,	NULL
the	NULL
estimated	NULL
TFIIH	NULL
yield	NULL
was	NULL
10	NULL
times	NULL
lower	NULL
than	NULL
that	NULL
starting	NULL
from	NULL
HeLa	NULL
cells	NULL
(	NULL
30	NULL
)	NULL
.	NULL

A	NULL
comparative	NULL
analysis	NULL
of	NULL
TFIIHmut	NULL
and	NULL
TFIIHwt	NULL
was	NULL
then	NULL
performed	NULL
for	NULL
each	NULL
of	NULL
the	NULL
known	NULL
enzymatic	NULL
activities	NULL
.	NULL

According	NULL
to	NULL
the	NULL
bidirectional	NULL
helicase	NULL
assay	NULL
,	NULL
we	NULL
observed	NULL
that	NULL
the	NULL
3	NULL
``	NULL
-	NULL
>	NULL
5	NULL
'	NULL
XPB	NULL
helicase	NULL
activity	NULL
of	NULL
TFIIHMmut	NULL
was	NULL
significantly	NULL
lower	NULL
(	NULL
40	NULL
%	NULL
)	NULL
than	NULL
that	NULL
of	NULL
TFIIHwt	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
,	NULL
compare	NULL
lanes	NULL
5	NULL
and	NULL
6	NULL
with	NULL
Zanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
despite	NULL
the	NULL
fact	NULL
that	NULL
the	NULL
mutation	NULL
occurs	NULL
outside	NULL
of	NULL
the	NULL
seven	NULL
helicase	NULL
motifs	NULL
and	NULL
the	NULL
putative	NULL
DNA-binding	NULL
domains	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

1B	NULL
and	NULL
Refs	NULL
.	NULL

23	NULL
,	NULL
29	NULL
,	NULL
and	NULL
31	NULL
)	NULL
.	NULL

It	NULL
is	NULL
interesting	NULL
to	NULL
note	NULL
that	NULL
the	NULL
5	NULL
'	NULL
-	NULL
>	NULL
3	NULL
'	NULL
XPD	NULL
helicase	NULL
activity	NULL
,	NULL
which	NULL
may	NULL
be	NULL
used	NULL
as	NULL
an	NULL
internal	NULL
control	NULL
,	NULL
is	NULL
almost	NULL
identical	NULL
in	NULL
both	NULL
TFIlHmut	NULL
and	NULL
TFIIHwt	NULL
,	NULL
a	NULL
result	NULL
that	NULL
we	NULL
repeatedly	NULL
observed	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
,	NULL
upper	NULL
and	NULL
lower	NULL
panels	NULL
)	NULL
.	NULL

This	NULL
demonstrates	NULL
that	NULL
our	NULL
TFIIH	NULL
preparations	NULL
do	NULL
not	NULL
contain	NULL
contaminants	NULL
that	NULL
may	NULL
inhibit	NULL
the	NULL
helicase	NULL
activity	NULL
.	NULL

To	NULL
further	NULL
confirm	NULL
that	NULL
the	NULL
difference	NULL
in	NULL
XPB	NULL
helicase	NULL
activity	NULL
between	NULL
TFIIHmut	NULL
and	NULL
TFIIHwt	NULL
was	NULL
not	NULL
the	NULL
result	NULL
of	NULL
some	NULL
contaminants	NULL
that	NULL
may	NULL
have	NULL
copurified	NULL
with	NULL
TFIIH	NULL
in	NULL
the	NULL
heparin-5PW	NULL
column	NULL
,	NULL
we	NULL
immunoprecipitated	NULL
in	NULL
parallel	NULL
TFI-IHwt-	NULL
and	NULL
TFIIHmut-heparin	NULL
fractions	NULL
with	NULL
antibodies	NULL
(	NULL
direct-ed	NULL
against	NULL
either	NULL
p62	NULL
or	NULL
Cdk7	NULL
(	NULL
MO15	NULL
)	NULL
,	NULL
two	NULL
subunits	NULL
of	NULL
the	NULL
TFIIH	NULL
complex	NULL
)	NULL
previously	NULL
coupled	NULL
to	NULL
protein	NULL
A-agarose	NULL
.	NULL

The	NULL
immunoprecipitates	NULL
were	NULL
sequentially	NULL
washed	NULL
with	NULL
0.15	NULL
and	NULL
0.50	NULL
m	NULL
KCl	NULL
adsorption	NULL
buffer	NULL
containing	NULL
0.1	NULL
%	NULL
Nonidet	NULL
P-40	NULL
.	NULL

After	NULL
being	NULL
equilibrated	NULL
in	NULL
the	NULL
helicase	NULL
assay	NULL
buffer	NULL
,	NULL
the	NULL
immunoprecipitated	NULL
TFIIH	NULL
complexes	NULL
were	NULL
separately	NULL
tested	NULL
in	NULL
the	NULL
bidirectional	NULL
helicase	NULL
assay	NULL
(	NULL
7	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2B	NULL
,	NULL
the	NULL
XPB/XPD	NULL
helicase	NULL
activity	NULL
ratio	NULL
measured	NULL
in	NULL
TFllHMmut	NULL
is	NULL
lower	NULL
than	NULL
in	NULL
TFIIHwt	NULL
,	NULL
thus	NULL
demonstrating	NULL
once	NULL
more	NULL
that	NULL
XPB	NULL
helicase	NULL
activity	NULL
in	NULL
TFIIHMmut	NULL
is	NULL
weaker	NULL
than	NULL
in	NULL
TFIIHwt	NULL
.	NULL

As	NULL
also	NULL
shown	NULL
by	NULL
the	NULL
helicase	NULL
assay	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
)	NULL
,	NULL
the	NULL
XPD	NULL
activities	NULL
in	NULL
TFIIHwt	NULL
and	NULL
TFIIHmut	NULL
were	NULL
identical	NULL
.	NULL

As	NULL
an	NULL
additional	NULL
control	NULL
,	NULL
we	NULL
analyzed	NULL
the	NULL
adsorbed	NULL
fractions	NULL
by	NULL
SDS-polyacryl-amide	NULL
gel	NULL
electrophoresis	NULL
.	NULL

Unfortunately	NULL
,	NULL
antibodies	NULL
as	NULL
well	NULL
as	NULL
part	NULL
of	NULL
protein	NULL
A	NULL
partially	NULL
masked	NULL
the	NULL
subunits	NULL
of	NULL
TFIIH	NULL
,	NULL
thus	NULL
rendering	NULL
the	NULL
silver-stained	NULL
protein	NULL
pattern	NULL
unreadable	NULL
.	NULL

Nev-ertheless	NULL
,	NULL
we	NULL
could	NULL
perform	NULL
Western	NULL
blotting	NULL
with	NULL
the	NULL
same	NULL
fractions	NULL
.	NULL

Antibodies	NULL
against	NULL
XPD	NULL
and	NULL
XPB	NULL
allowed	NULL
us	NULL
to	NULL
demonstrate	NULL
that	NULL
both	NULL
polypeptides	NULL
were	NULL
not	NULL
degraded	NULL
in	NULL
either	NULL
TFIIHwt	NULL
or	NULL
TFllHMmut	NULL
and	NULL
that	NULL
the	NULL
levels	NULL
of	NULL
XPB	NULL
and	NULL
XPD	NULL
present	NULL
in	NULL
each	NULL
immunoprecipitate	NULL
were	NULL
identical	NULL
.	NULL

All	NULL
together	NULL
,	NULL
these	NULL
results	NULL
demonstrate	NULL
the	NULL
weaker	NULL
XPB	NULL
helicase	NULL
activity	NULL
in	NULL
TFIIHmut	NULL
compared	NULL
with	NULL
TFIIHwt	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
DNA-dependent	NULL
ATPase	NULL
activity	NULL
(	NULL
0.18	NULL
pmol	NULL
of	NULL
P	NULL
;	NULL
released	NULL
per	NULL
ng	NULL
of	NULL
protein/h	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

2C	NULL
)	NULL
as	NULL
well	NULL
as	NULL
the	NULL
CTD	NULL
kinase	NULL
activity	NULL
(	NULL
0.18	NULL
pmol	NULL
of	NULL
PO	NULL
,	NULL
incorporated	NULL
per	NULL
ng	NULL
of	NULL
protein/h	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

2D	NULL
)	NULL
of	NULL
TFllHMmut	NULL
appeared	NULL
unaffected	NULL
compared	NULL
with	NULL
TFIIHwt	NULL
(	NULL
0.18	NULL
pmol/ng/h	NULL
for	NULL
ATPase	NULL
and	NULL
0.15	NULL
pmol/ng/h	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
A	NULL
3	NULL
'	NULL
-5	NULL
'	NULL
XPB	NULL
Helicase	NULL
Defect	NULL
in	NULL
TFIIH	NULL
1	NULL
A	NULL
TFIIHwt	NULL
TEllHmut	NULL
B	NULL
+	NULL
-	NULL
l	NULL
-	NULL
{	NULL
XPB	NULL
XPD	NULL
n	NULL
j	NULL
«	NULL
-XPD	NULL
Helicase	NULL
6	NULL
-	NULL
>	NULL
31	NULL
0.5	NULL
|	NULL
ia	NULL
+-xPB	NULL
U	NULL
WW	NULL
=n	NULL
;	NULL
z	NULL
,	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
End	NULL
TFiBW	NULL
TEMA	NULL
C	NULL
[	NULL
22	NULL
:	NULL
THiHmut	NULL
wt	NULL
mut	NULL
o	NULL
&	NULL
<	NULL
C	NULL
TElHwt_	NULL
TFilHmut	NULL
&	NULL
so	NULL
F-	NULL
__	NULL
ee	NULL
}	NULL
E	NULL
60	NULL
ATPase	NULL
*	NULL
*	NULL
#	NULL
*	NULL
@	NULL
~	NULL
*	NULL
*	NULL
@	NULL
-Pi	NULL
g	NULL
1	NULL
2	NULL
8	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8a	NULL
940	NULL
§	NULL
``	NULL
D	NULL
TFilHwt	NULL
_	NULL
TFEilHmut	NULL
€	NULL
zo	NULL
Fo	NULL
cus	NULL
lae	NULL
=	NULL
.2	NULL
2	NULL
Kinase	NULL
``	NULL
;	NULL
sini	NULL
lity	NULL
»	NULL
.	NULL

»	NULL
.	NULL

aah	NULL
atl	NULL
<	NULL
-	NULL
ctci4	NULL
XPB	NULL
XPD	NULL
‘	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
910	NULL
Fic	NULL
.	NULL

2	NULL
.	NULL

Comparison	NULL
of	NULL
TFIIH	NULL
enzymatic	NULL
activities	NULL
.	NULL

The	NULL
antibodies	NULL
against	NULL
XPB	NULL
were	NULL
also	NULL
used	NULL
to	NULL
measure	NULL
quantitatively	NULL
the	NULL
relative	NULL
amount	NULL
of	NULL
XPB	NULL
in	NULL
each	NULL
fraction	NULL
;	NULL
both	NULL
fractions	NULL
of	NULL
TFIIHmut	NULL
and	NULL
TFIIHwt	NULL
were	NULL
then	NULL
adjusted	NULL
to	NULL
contain	NULL
the	NULL
same	NULL
amount	NULL
of	NULL
XPB/microliter	NULL
.	NULL

Partially	NULL
purified	NULL
TFIIHmut	NULL
(	NULL
7	NULL
ng/g	NULL
!	NULL
)	NULL

and	NULL
TFIIHwt	NULL
(	NULL
7	NULL
ng/ul	NULL
)	NULL
were	NULL
tested	NULL
for	NULL
their	NULL
enzymatic	NULL
activities	NULL
.	NULL

A	NULL
,	NULL
in	NULL
the	NULL
bidirectional	NULL
helicase	NULL
assay	NULL
(	NULL
heparin	NULL
fractions	NULL
)	NULL
,	NULL
1	NULL
and	NULL
2	NULL
ul	NULL
of	NULL
TFIIHwt	NULL
(	NULL
upper	NULL
panel	NULL
,	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
,	NULL
respectively	NULL
)	NULL
or	NULL
TFIIHMmut	NULL
(	NULL
lanes	NULL
5	NULL
and	NULL
6	NULL
,	NULL
respectively	NULL
)	NULL
were	NULL
used	NULL
.	NULL

Controls	NULL
were	NULL
carried	NULL
out	NULL
with	NULL
substrate	NULL
heated	NULL
for	NULL
2	NULL
min	NULL
at	NULL
100	NULL
°C	NULL
(	NULL
+	NULL
,	NULL
lane	NULL
1	NULL
)	NULL
and	NULL
with	NULL
unheated	NULL
substrate	NULL
without	NULL
proteins	NULL
(	NULL
-	NULL
,	NULL
lane	NULL
2	NULL
)	NULL
.	NULL

The	NULL
XPB	NULL
and	NULL
XPD	NULL
helicase	NULL
activities	NULL
of	NULL
three	NULL
independent	NULL
purifications	NULL
of	NULL
TFIIHwt	NULL
and	NULL
TFIIHmut	NULL
were	NULL
measured	NULL
and	NULL
standardized	NULL
to	NULL
XPBwt	NULL
and	NULL
XPDwt	NULL
(	NULL
FZower	NULL
panel	NULL
)	NULL
.	NULL

The	NULL
XPB	NULL
and	NULL
XPD	NULL
values	NULL
of	NULL
TFIIHwt	NULL
were	NULL
each	NULL
considered	NULL
to	NULL
be	NULL
100	NULL
%	NULL
.	NULL

The	NULL
scanned	NULL
XPB	NULL
and	NULL
XPD	NULL
values	NULL
for	NULL
TFIIHmut	NULL
are	NULL
reported	NULL
in	NULL
the	NULL
lower	NULL
panel	NULL
.	NULL

The	NULL
means	NULL
+	NULL
S.E	NULL
.	NULL

are	NULL
indicated	NULL
.	NULL

The	NULL
total	NULL
level	NULL
of	NULL
available	NULL
probe	NULL
was	NULL
determined	NULL
by	NULL
heat	NULL
denaturation	NULL
of	NULL
substrate	NULL
(	NULL
upper	NULL
panel	NULL
,	NULL
lane	NULL
1	NULL
)	NULL
.	NULL

XPB	NULL
and	NULL
XPD	NULL
activities	NULL
of	NULL
TFIIHwt	NULL
were	NULL
measured	NULL
as	NULL
4.3	NULL
and	NULL
1.9	NULL
%	NULL
,	NULL
respectively	NULL
,	NULL
of	NULL
bound	NULL
oligonucleotide	NULL
displaced	NULL
per	NULL
h/ng	NULL
of	NULL
TFIIH	NULL
fraction	NULL
standardized	NULL
of	NULL
XPB	NULL
protein	NULL
.	NULL

B	NULL
,	NULL
the	NULL
heparin	NULL
fractions	NULL
(	NULL
100	NULL
ul	NULL
)	NULL
were	NULL
immunoprecipi-tated	NULL
,	NULL
conjugated	NULL
to	NULL
protein	NULL
A	NULL
,	NULL
extensively	NULL
washed	NULL
,	NULL
and	NULL
tested	NULL
in	NULL
the	NULL
bidirectional	NULL
helicase	NULL
assay	NULL
as	NULL
indicated	NULL
under	NULL
``	NULL
Experimental	NULL
Proce-dures	NULL
``	NULL
.	NULL

The	NULL
figure	NULL
represents	NULL
the	NULL
XPB/XPD	NULL
helicase	NULL
activity	NULL
ratio	NULL
for	NULL
TFIIHwt	NULL
and	NULL
TFIIHmut	NULL
proteins	NULL
.	NULL

In	NULL
this	NULL
case	NULL
,	NULL
as	NULL
previously	NULL
stated	NULL
,	NULL
if	NULL
the	NULL
observed	NULL
XPB	NULL
and	NULL
XPD	NULL
helicase	NULL
values	NULL
are	NULL
represented	NULL
as	NULL
100	NULL
%	NULL
,	NULL
the	NULL
XPB/XPD	NULL
ratio	NULL
will	NULL
be	NULL
1	NULL
.	NULL

The	NULL
XPB	NULL
and	NULL
XPD	NULL
activities	NULL
of	NULL
TFIIHmut	NULL
were	NULL
then	NULL
determined	NULL
by	NULL
comparison	NULL
with	NULL
wild-type	NULL
levels	NULL
;	NULL
the	NULL
XPB/	NULL
XPD	NULL
ratio	NULL
calculated	NULL
is	NULL
~0.4	NULL
.	NULL

C	NULL
and	NULL
D	NULL
,	NULL
in	NULL
DNA-dependent	NULL
ATPase	NULL
and	NULL
kinase	NULL
assays	NULL
,	NULL
1	NULL
,	NULL
2	NULL
,	NULL
4	NULL
,	NULL
and	NULL
8	NULL
pl	NULL
of	NULL
TFIIHwt-heparin	NULL
(	NULL
Zanes	NULL
3-6	NULL
,	NULL
respectively	NULL
)	NULL
or	NULL
TFIIHmut-heparin	NULL
(	NULL
fares	NULL
7-10	NULL
,	NULL
respectively	NULL
)	NULL
fractions	NULL
were	NULL
used	NULL
.	NULL

Controls	NULL
were	NULL
carried	NULL
out	NULL
without	NULL
(	NULL
-	NULL
,	NULL
lame	NULL
2	NULL
)	NULL
and	NULL
with	NULL
(	NULL
+	NULL
,	NULL
lane	NULL
1	NULL
)	NULL
the	NULL
Helia	NULL
TFIIH	NULL
factor	NULL
(	NULL
6	NULL
and	NULL
2	NULL
ul	NULL
,	NULL
respectively	NULL
,	NULL
at	NULL
a	NULL
concentration	NULL
of	NULL
~3-4	NULL
ng/ul	NULL
)	NULL
.	NULL

The	NULL
arrows	NULL
indicate	NULL
the	NULL
products	NULL
from	NULL
each	NULL
assay	NULL
,	NULL
the	NULL
inorganic	NULL
phosphates	NULL
(	NULL
P	NULL
?	NULL
)	NULL

,	NULL
and	NULL
the	NULL
phosphorylated	NULL
oligopeptide	NULL
mimicking	NULL
CTD	NULL
(	NULL
ctd4	NULL
)	NULL
.	NULL

for	NULL
CTD	NULL
kinase	NULL
)	NULL
.	NULL

In	NULL
this	NULL
regard	NULL
,	NULL
one	NULL
has	NULL
to	NULL
take	NULL
into	NULL
account	NULL
that	NULL
the	NULL
DNA-dependent	NULL
ATPase	NULL
activity	NULL
of	NULL
TFIIH	NULL
is	NULL
the	NULL
result	NULL
of	NULL
the	NULL
combined	NULL
action	NULL
of	NULL
the	NULL
XPD	NULL
and	NULL
XPB	NULL
helicases	NULL
(	NULL
7	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
the	NULL
C	NULL
terminus	NULL
frameshift	NULL
in	NULL
XPBmut	NULL
does	NULL
not	NULL
alter	NULL
the	NULL
ATP-	NULL
and	NULL
DNA-binding	NULL
domains	NULL
of	NULL
the	NULL
protein	NULL
.	NULL

The	NULL
kinase	NULL
activity	NULL
resides	NULL
primarily	NULL
in	NULL
the	NULL
Cdk7	NULL
(	NULL
MO15	NULL
)	NULL
subunit	NULL
of	NULL
TFIIH	NULL
(	NULL
10	NULL
)	NULL
.	NULL

It	NULL
is	NULL
of	NULL
interest	NULL
to	NULL
note	NULL
that	NULL
we	NULL
observed	NULL
reproducibly	NULL
a	NULL
slight	NULL
difference	NULL
between	NULL
the	NULL
kinase	NULL
activities	NULL
of	NULL
TFl	NULL
!	NULL

lHMmut	NULL
and	NULL
TFIIHwt	NULL
(	NULL
Fig	NULL
.	NULL

2D	NULL
)	NULL
.	NULL

This	NULL
may	NULL
reflect	NULL
the	NULL
change	NULL
of	NULL
mutated	NULL
XPB	NULL
,	NULL
which	NULL
modulates	NULL
the	NULL
affinity	NULL
of	NULL
TFIlHmut	NULL
for	NULL
the	NULL
CTD	NULL
substrate	NULL
and	NULL
may	NULL
result	NULL
in	NULL
a	NULL
slightly	NULL
increased	NULL
specific	NULL
activity	NULL
.	NULL

This	NULL
observation	NULL
also	NULL
strengthens	NULL
the	NULL
significance	NULL
of	NULL
the	NULL
decrease	NULL
in	NULL
the	NULL
helicase	NULL
activity	NULL
of	NULL
TFIlHmut	NULL
.	NULL

NER	NULL
and	NULL
Transcription	NULL
Activities	NULL
of	NULL
TFllHmut	NULL
in	NULL
Vitro	NULL
and	NULL
in	NULL
Vivo-TF	NULL
!	NULL

lHMmut	NULL
and	NULL
TFIIHwt	NULL
were	NULL
then	NULL
tested	NULL
for	NULL
their	NULL
ability	NULL
to	NULL
restore	NULL
both	NULL
the	NULL
DNA	NULL
repair	NULL
and	NULL
transcription	NULL
reac-tions	NULL
.	NULL

When	NULL
added	NULL
to	NULL
a	NULL
reconstituted	NULL
in	NULL
vitro	NULL
transcription	NULL
assay	NULL
lacking	NULL
TFIIH	NULL
,	NULL
both	NULL
TFIIHwt	NULL
and	NULL
TFIlHmut	NULL
preparations	NULL
restored	NULL
transcription	NULL
initiated	NULL
from	NULL
the	NULL
adenovirus	NULL
type	NULL
2	NULL
major	NULL
late	NULL
promoter	NULL
as	NULL
observed	NULL
by	NULL
the	NULL
synthesis	NULL
of	NULL
a	NULL
309-	NULL
15901	NULL
nucleotide-long	NULL
run-off	NULL
transcript	NULL
.	NULL

However	NULL
,	NULL
TFlHMmut	NULL
was	NULL
25-30	NULL
%	NULL
less	NULL
active	NULL
than	NULL
TFIIHwt	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
;	NULL
see	NULL
also	NULL
the	NULL
curves	NULL
in	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

This	NULL
deficiency	NULL
in	NULL
transcription	NULL
was	NULL
observed	NULL
reproducibly	NULL
with	NULL
several	NULL
different	NULL
preparations	NULL
of	NULL
TFIlHMHmut	NULL
and	NULL
thus	NULL
seems	NULL
to	NULL
be	NULL
a	NULL
consistent	NULL
intrinsic	NULL
feature	NULL
of	NULL
the	NULL
TFIIHmut	NULL
complex	NULL
.	NULL

When	NULL
added	NULL
to	NULL
an	NULL
XPB-deficient	NULL
DNA	NULL
repair	NULL
extract	NULL
,	NULL
TFIIHmut	NULL
was	NULL
unable	NULL
to	NULL
rescue	NULL
the	NULL
repair	NULL
reaction	NULL
,	NULL
whereas	NULL
the	NULL
addition	NULL
of	NULL
TFIIHwt	NULL
restored	NULL
the	NULL
DNA	NULL
repair	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

3C	NULL
,	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
,	NULL
respectively	NULL
)	NULL
.	NULL

To	NULL
assess	NULL
the	NULL
in	NULL
vivo	NULL
NER	NULL
activity	NULL
of	NULL
TFIIHMHmut	NULL
and	NULL
TFIIHwt	NULL
,	NULL
TFIIH-heparin-5PW	NULL
fractions	NULL
were	NULL
microinjected	NULL
into	NULL
living	NULL
fibroblasts	NULL
of	NULL
different	NULL
NER-deficient	NULL
complementation	NULL
groups	NULL
(	NULL
Table	NULL
I	NULL
)	NULL
.	NULL

The	NULL
effect	NULL
of	NULL
the	NULL
injected	NULL
TFIIH	NULL
on	NULL
the	NULL
repair	NULL
capacity	NULL
of	NULL
the	NULL
cells	NULL
was	NULL
measured	NULL
by	NULL
UV-induced	NULL
unscheduled	NULL
DNA	NULL
synthesis	NULL
,	NULL
determined	NULL
immediately	NULL
after	NULL
microinjection	NULL
and	NULL
UV	NULL
irradiation	NULL
by	NULL
incubation	NULL
of	NULL
the	NULL
slides	NULL
with	NULL
the	NULL
injected	NULL
cells	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
dine	NULL
for	NULL
a	NULL
period	NULL
of	NULL
2	NULL
h	NULL
to	NULL
label	NULL
DNA	NULL
repair	NULL
patches	NULL
.	NULL

Incorporated	NULL
[	NULL
°H	NULL
]	NULL
thymidine	NULL
was	NULL
visualized	NULL
by	NULL
in	NULL
situ	NULL
autoradiography	NULL
and	NULL
quantified	NULL
by	NULL
counting	NULL
silver	NULL
grains	NULL
above	NULL
nuclei	NULL
(	NULL
14	NULL
)	NULL
.	NULL

Microinjection	NULL
of	NULL
TFIIHwt	NULL
into	NULL
XPB-deficient	NULL
cells	NULL
(	NULL
XPCS1BA	NULL
)	NULL
restored	NULL
the	NULL
UV-induced	NULL
unscheduled	NULL
DNA	NULL
synthesis	NULL
activity	NULL
to	NULL
the	NULL
normal	NULL
level	NULL
(	NULL
Table	NULL
I	NULL
)	NULL
,	NULL
whereas	NULL
microinjection	NULL
of	NULL
TFIIHmut	NULL
had	NULL
no	NULL
effect	NULL
(	NULL
compared	NULL
with	NULL
noninjected	NULL
cells	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
microinjection	NULL
of	NULL
TFIIHmut	NULL
in	NULL
XPD-	NULL
or	NULL
TTD-A-deficient	NULL
cells	NULL
restored	NULL
DNA	NULL
repair	NULL
to	NULL
virtually	NULL
normal	NULL
levels	NULL
.	NULL

This	NULL
supports	NULL
the	NULL
idea	NULL
that	NULL
some	NULL
subunits	NULL
of	NULL
TFIIH	NULL
can	NULL
exchange	NULL
during	NULL
the	NULL
repair	NULL
reaction	NULL
and	NULL
are	NULL
thus	NULL
able	NULL
to	NULL
reconstitute	NULL
an	NULL
active	NULL
TFIIH	NULL
repair	NULL
factor	NULL
with	NULL
wild-type	NULL
XPB	NULL
,	NULL
XPD	NULL
,	NULL
and	NULL
TTD-A	NULL
gene	NULL
products	NULL
in	NULL
vivo	NULL
within	NULL
a	NULL
period	NULL
of	NULL
2	NULL
h	NULL
after	NULL
microinjection	NULL
.	NULL

Microinjection	NULL
of	NULL
TFIIHMmut	NULL
or	NULL
TFIIHwt	NULL
fractions	NULL
in	NULL
XPD-deficient	NULL
cells	NULL
restored	NULL
the	NULL
NER	NULL
activity	NULL
;	NULL
this	NULL
demonstrates	NULL
that	NULL
TFIlHmut	NULL
contains	NULL
an	NULL
active	NULL
XPD	NULL
subunit	NULL
(	NULL
Table	NULL
D	NULL
)	NULL
.	NULL

Recombinant	NULL
XPBut	NULL
and	NULL
XPBmut	NULL
Activities-To	NULL
exclude	NULL
the	NULL
possibility	NULL
that	NULL
other	NULL
defects	NULL
in	NULL
the	NULL
mutated	NULL
cell	NULL
line	NULL
may	NULL
result	NULL
in	NULL
a	NULL
decrease	NULL
in	NULL
the	NULL
3	NULL
'	NULL
-	NULL
>	NULL
5	NULL
'	NULL
helicase	NULL
of	NULL
the	NULL
TFIlHmut	NULL
complex	NULL
,	NULL
we	NULL
analyzed	NULL
the	NULL
intrinsic	NULL
activity	NULL
of	NULL
the	NULL
mutated	NULL
XPB	NULL
polypep-tide	NULL
.	NULL

The	NULL
mutation	NULL
identified	NULL
in	NULL
patient	NULL
XP11BE	NULL
was	NULL
reproduced	NULL
by	NULL
site-directed	NULL
mutagenesis	NULL
,	NULL
and	NULL
the	NULL
modified	NULL
(	NULL
rXPB-mut	NULL
)	NULL
and	NULL
wild-type	NULL
(	NULL
rXPBwt	NULL
)	NULL
XPB	NULL
recombinants	NULL
were	NULL
overexpressed	NULL
as	NULL
glutathione	NULL
S-transferase	NULL
fusion	NULL
polypeptides	NULL
in	NULL
E.	NULL
coli	NULL
.	NULL

Both	NULL
polypeptides	NULL
were	NULL
purified	NULL
by	NULL
affinity	NULL
chroma-tography	NULL
through	NULL
a	NULL
glutathione-Sepharose	NULL
column	NULL
(	NULL
29	NULL
)	NULL
.	NULL

The	NULL
flow-through	NULL
and	NULL
eluate	NULL
fractions	NULL
obtained	NULL
after	NULL
extensive	NULL
washing	NULL
were	NULL
assayed	NULL
for	NULL
3	NULL
'	NULL
-	NULL
>	NULL
5	NULL
'	NULL
helicase	NULL
and	NULL
DNA-dependent	NULL
ATPase	NULL
activities	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

4A	NULL
,	NULL
rXPBmut	NULL
has	NULL
a	NULL
very	NULL
weak	NULL
helicase	NULL
activity	NULL
(	NULL
Zanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
compared	NULL
with	NULL
rXPBwt	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
while	NULL
the	NULL
ATPase	NULL
activity	NULL
of	NULL
purified	NULL
appeared	NULL
unaffected	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
,	NULL
rXPBmut	NULL
was	NULL
largely	NULL
devoid	NULL
of	NULL
this	NULL
activity	NULL
(	NULL
0.0045	NULL
pmol	NULL
of	NULL
P	NULL
;	NULL
released	NULL
per	NULL
ng/h	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
,	NULL
compare	NULL
lanes	NULL
8-11	NULL
with	NULL
lane	NULL
1	NULL
)	NULL
compared	NULL
with	NULL
rXPBwt	NULL
(	NULL
0.018	NULL
pmol/ng/h	NULL
)	NULL
.	NULL

Note	NULL
that	NULL
the	NULL
XPB	NULL
recombinants	NULL
present	NULL
a	NULL
much	NULL
lower	NULL
activity	NULL
than	NULL
TFIIH	NULL
,	NULL
likely	NULL
because	NULL
of	NULL
incomplete	NULL
unfolding	NULL
or	NULL
processing	NULL
in	NULL
£	NULL
.	NULL

coli	NULL
;	NULL
also	NULL
,	NULL
XPB	NULL
may	NULL
adopt	NULL
a	NULL
more	NULL
favorable	NULL
conformation	NULL
when	NULL
in	NULL
the	NULL
context	NULL
of	NULL
the	NULL
whole	NULL
TFIIH	NULL
.	NULL

DISCUSSION	NULL
It	NULL
was	NULL
previously	NULL
shown	NULL
that	NULL
a	NULL
frameshift	NULL
mutation	NULL
at	NULL
the	NULL
3'-terminus	NULL
of	NULL
the	NULL
XPB	NULL
gene	NULL
leads	NULL
to	NULL
a	NULL
virtually	NULL
complete	NULL
inactivation	NULL
of	NULL
the	NULL
NER	NULL
pathway	NULL
(	NULL
23	NULL
)	NULL
.	NULL

The	NULL
function	NULL
can	NULL
be	NULL
replaced	NULL
by	NULL
the	NULL
introduction	NULL
of	NULL
the	NULL
wild-type	NULL
gene	NULL
either	NULL
by	NULL
microinjection	NULL
into	NULL
XP-B	NULL
primary	NULL
fibroblasts	NULL
or	NULL
by	NULL
gene	NULL
trans-fection	NULL
into	NULL
cells	NULL
from	NULL
the	NULL
UV-sensitive	NULL
mutants	NULL
of	NULL
rodent	NULL
complementation	NULL
group	NULL
3	NULL
,	NULL
the	NULL
Chinese	NULL
hamster	NULL
equivalent	NULL
of	NULL
XP-B	NULL
(	NULL
14	NULL
)	NULL
.	NULL

Patient	NULL
XP11BE	NULL
,	NULL
the	NULL
first	NULL
documented	NULL
case	NULL
of	NULL
XP-B	NULL
,	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
15902	NULL
A	NULL
3	NULL
``	NULL
-5	NULL
'	NULL
XPB	NULL
Helicase	NULL
Defect	NULL
in	NULL
TFIIH	NULL
A	NULL
TFIIH	NULL
wt	NULL
_	NULL
TFH	NULL
mut	NULL
C	NULL
NER	NULL
Fo=	NULL
us-	NULL
]	NULL
C	NULL
Transcription	NULL
|	NULL
@	NULL
||	NULL
aay	NULL
we	NULL
»	NULL
+-	NULL
309nt	NULL
TFIIH	NULL
wt	NULL
=-	NULL
-	NULL
1	NULL
2	NULL
3	NULL
4	NULL
50	NULL
6	NULL
7	NULL
8	NULL
$	NULL
10	NULL
112	NULL
TFIIA	NULL
mut	NULL
-	NULL
_-	NULL
4	NULL
--	NULL
®	NULL
Autoradio	NULL
B	NULL
Transcription	NULL
ao	NULL
EtBr	NULL
20	NULL
mut	NULL
Arbitrary	NULL
Units	NULL
0	NULL
0.5	NULL
1	NULL
2	NULL
(	NULL
uh	NULL
Fic	NULL
.	NULL

3	NULL
.	NULL

Transcription	NULL
and	NULL
NER	NULL
activities	NULL
of	NULL
TFllHmut	NULL
and	NULL
TFIIHwt	NULL
.	NULL

A	NULL
shows	NULL
the	NULL
transcription	NULL
activity	NULL
of	NULL
increasing	NULL
amounts	NULL
(	NULL
0.5	NULL
,	NULL
1	NULL
,	NULL
2	NULL
,	NULL
4	NULL
,	NULL
and	NULL
8	NULL
ul	NULL
;	NULL
7	NULL
ng/ul	NULL
)	NULL
of	NULL
TFIIHwt	NULL
(	NULL
lanes	NULL
3-7	NULL
,	NULL
respectively	NULL
)	NULL
or	NULL
TFlIHmut	NULL
(	NULL
anes	NULL
8-12	NULL
,	NULL
respectively	NULL
)	NULL
,	NULL
and	NULL
B	NULL
shows	NULL
the	NULL
densitometer	NULL
quantitation	NULL
of	NULL
the	NULL
data	NULL
.	NULL

The	NULL
values	NULL
are	NULL
expressed	NULL
in	NULL
arbitrary	NULL
units	NULL
.	NULL

Lane	NULL
1	NULL
,	NULL
positive	NULL
control	NULL
(	NULL
+	NULL
)	NULL
using	NULL
highly	NULL
purified	NULL
HeLa	NULL
TFIIH	NULL
(	NULL
~20	NULL
ng	NULL
)	NULL
;	NULL
lane	NULL
2	NULL
,	NULL
negative	NULL
control	NULL
(	NULL
-	NULL
)	NULL
.	NULL

The	NULL
arrow	NULL
indicates	NULL
the	NULL
specific	NULL
transcript	NULL
(	NULL
nt	NULL
,	NULL
nucleotides	NULL
)	NULL
.	NULL

In	NULL
C	NULL
,	NULL
100	NULL
ng	NULL
of	NULL
purified	NULL
TFIIHwt	NULL
(	NULL
Zane	NULL
4	NULL
)	NULL
or	NULL
TFIIHMmut	NULL
(	NULL
Zane	NULL
3	NULL
)	NULL
was	NULL
tested	NULL
in	NULL
an	NULL
in	NULL
vitro	NULL
DNA	NULL
repair	NULL
assay	NULL
for	NULL
the	NULL
ability	NULL
to	NULL
complement	NULL
an	NULL
XPB-deficient	NULL
extract	NULL
.	NULL

Use	NULL
of	NULL
undamaged	NULL
(	NULL
-	NULL
)	NULL
and	NULL
aminoacetylfluorene-damaged	NULL
(	NULL
+	NULL
)	NULL
DNA	NULL
substrates	NULL
is	NULL
indicated	NULL
.	NULL

The	NULL
upper	NULL
panel	NULL
shows	NULL
the	NULL
[	NULL
a	NULL
«	NULL
-*	NULL
``	NULL
P	NULL
]	NULL
dATP	NULL
incorporation	NULL
that	NULL
indicates	NULL
the	NULL
repair	NULL
activity	NULL
(	NULL
Autoradio	NULL
)	NULL
,	NULL
and	NULL
the	NULL
lower	NULL
panel	NULL
shows	NULL
the	NULL
ethidium	NULL
bromide-stained	NULL
DNA	NULL
gel	NULL
.	NULL

C	NULL
,	NULL
positive	NULL
control	NULL
using	NULL
HeLa	NULL
whole	NULL
cell	NULL
extract	NULL
.	NULL

TaBL®	NULL
I	NULL
Microinjection	NULL
of	NULL
TFllHmut	NULL
(	NULL
XP11BE	NULL
,	NULL
GM2252A	NULL
cell	NULL
line	NULL
)	NULL
and	NULL
TFIIHuwt	NULL
(	NULL
GM1855	NULL
cell	NULL
line	NULL
)	NULL
in	NULL
various	NULL
XP	NULL
and	NULL
TTD	NULL
complementation	NULL
groups	NULL
UDS	NULL
levels	NULL
``	NULL
TFIIHmut	NULL
TFIHwt	NULL
Noninjected	NULL
XPCSIBA	NULL
(	NULL
XP-B	NULL
)	NULL
14	NULL
106	NULL
14	NULL
XP1IBR	NULL
(	NULL
XP-D	NULL
)	NULL
107	NULL
107	NULL
20	NULL
TTDIBR	NULL
(	NULL
TTD-A	NULL
)	NULL
91	NULL
92	NULL
6	NULL
*	NULL
Percent	NULL
of	NULL
unscheduled	NULL
DNA	NULL
synthesis	NULL
(	NULL
UDS	NULL
)	NULL
of	NULL
normal	NULL
fibroblasts	NULL
assessed	NULL
in	NULL
parallel	NULL
.	NULL

A	NULL
rXPB	NULL
Poy	NULL
9	NULL
wt	NULL
mut	NULL
a	NULL
``	NULL
_-	NULL
``	NULL
_	NULL
,	NULL
+	NULL
Helicase	NULL
«	NULL
+-	NULL
24nt	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
B	NULL
_	NULL
rXPBmut	NULL
Po-	NULL
--	NULL
a	NULL
PETA	NULL
FT	NULL
_-	NULL
]	NULL
ATPase	NULL
@	NULL
*	NULL
C	NULL
<	NULL
-	NULL
Pi	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
910	NULL
11	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

Helicase	NULL
and	NULL
ATPase	NULL
activities	NULL
of	NULL
mutated	NULL
(	NULL
rXPBmut	NULL
;	NULL
10	NULL
ng/pl	NULL
)	NULL
and	NULL
wild-type	NULL
(	NULL
rXPBwt	NULL
;	NULL
10	NULL
ng/ul	NULL
)	NULL
XPB	NULL
recombinants	NULL
.	NULL

A	NULL
:	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
,	NULL
1	NULL
and	NULL
2	NULL
pl	NULL
of	NULL
rXPBwt	NULL
,	NULL
respectively	NULL
;	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
,	NULL
1	NULL
and	NULL
2	NULL
ul	NULL
of	NULL
rXPBmut	NULL
,	NULL
respectively	NULL
;	NULL
lame	NULL
5	NULL
,	NULL
negative	NULL
control	NULL
(	NULL
-	NULL
)	NULL
;	NULL
lane	NULL
6	NULL
,	NULL
positive	NULL
control	NULL
(	NULL
+	NULL
)	NULL
(	NULL
substrate	NULL
heated	NULL
for	NULL
2	NULL
min	NULL
at	NULL
100	NULL
°C	NULL
)	NULL
.	NULL

B	NULL
:	NULL
lane	NULL
1	NULL
,	NULL
negative	NULL
control	NULL
(	NULL
-	NULL
)	NULL
;	NULL
lanes	NULL
3-6	NULL
,	NULL
1	NULL
,	NULL
2	NULL
,	NULL
4	NULL
,	NULL
and	NULL
8	NULL
ul	NULL
of	NULL
rXPBwt	NULL
,	NULL
respectively	NULL
;	NULL
lane	NULL
7	NULL
,	NULL
flow-through	NULL
(	NULL
FT	NULL
)	NULL
fraction	NULL
from	NULL
the	NULL
glutathione	NULL
S-transferase	NULL
column	NULL
;	NULL
lanes	NULL
8-11	NULL
,	NULL
1	NULL
,	NULL
2	NULL
,	NULL
4	NULL
,	NULL
and	NULL
8	NULL
ul	NULL
of	NULL
rXPBmut	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
arrows	NULL
indicate	NULL
the	NULL
displaced	NULL
labeled	NULL
oligonucleotide	NULL
(	NULL
24n¢	NULL
)	NULL
and	NULL
the	NULL
P	NULL
,	NULL
;	NULL
generated	NULL
.	NULL

presented	NULL
a	NULL
perplexing	NULL
combination	NULL
of	NULL
XP	NULL
and	NULL
CS	NULL
features	NULL
.	NULL

The	NULL
identification	NULL
of	NULL
two	NULL
more	NULL
cases	NULL
,	NULL
one	NULL
with	NULL
XP/CS	NULL
and	NULL
one	NULL
with	NULL
TTD	NULL
(	NULL
21	NULL
)	NULL
,	NULL
in	NULL
this	NULL
very	NULL
rare	NULL
group	NULL
of	NULL
XP	NULL
has	NULL
further	NULL
broadened	NULL
the	NULL
range	NULL
and	NULL
heterogeneity	NULL
of	NULL
the	NULL
clinical	NULL
symptoms	NULL
.	NULL

The	NULL
discovery	NULL
that	NULL
the	NULL
XPB	NULL
and	NULL
XPD	NULL
genes	NULL
encode	NULL
DNA	NULL
helicases	NULL
that	NULL
are	NULL
subunits	NULL
of	NULL
TFIIH	NULL
,	NULL
a	NULL
multisubunit	NULL
complex	NULL
engaged	NULL
not	NULL
only	NULL
in	NULL
NER	NULL
,	NULL
but	NULL
also	NULL
in	NULL
basal	NULL
transcription	NULL
and	NULL
potentially	NULL
linked	NULL
with	NULL
cell	NULL
cycle	NULL
regulation	NULL
,	NULL
has	NULL
given	NULL
a	NULL
new	NULL
perspective	NULL
to	NULL
these	NULL
clinical	NULL
conditions	NULL
.	NULL

This	NULL
study	NULL
provides	NULL
evidence	NULL
in	NULL
accordance	NULL
with	NULL
the	NULL
idea	NULL
that	NULL
the	NULL
non-repair	NULL
features	NULL
associated	NULL
with	NULL
CS	NULL
and	NULL
TTD	NULL
could	NULL
be	NULL
due	NULL
to	NULL
the	NULL
deficiency	NULL
of	NULL
TFIIH	NULL
at	NULL
the	NULL
level	NULL
of	NULL
transcription	NULL
.	NULL

TFIIH	NULL
purified	NULL
from	NULL
XP11BE	NULL
not	NULL
only	NULL
displays	NULL
a	NULL
profound	NULL
NER	NULL
defect	NULL
,	NULL
but	NULL
also	NULL
an	NULL
impairment	NULL
of	NULL
the	NULL
basal	NULL
transcription	NULL
function	NULL
.	NULL

Biochemical	NULL
Consequences	NULL
of	NULL
the	NULL
XP11BE	NULL
Mutation	NULL
in	NULL
XPB-The	NULL
XP11BE	NULL
frameshift	NULL
,	NULL
which	NULL
converts	NULL
the	NULL
C-terminal	NULL
41	NULL
amino	NULL
acids	NULL
of	NULL
the	NULL
XPB	NULL
polypeptide	NULL
to	NULL
a	NULL
nonsense	NULL
sequence	NULL
,	NULL
clearly	NULL
decreases	NULL
its	NULL
3	NULL
'	NULL
-	NULL
>	NULL
5	NULL
'	NULL
helicase	NULL
activity	NULL
even	NULL
though	NULL
this	NULL
region	NULL
of	NULL
the	NULL
C	NULL
terminus	NULL
does	NULL
not	NULL
harbor	NULL
any	NULL
of	NULL
the	NULL
sequence	NULL
motifs	NULL
characteristic	NULL
of	NULL
DNA	NULL
or	NULL
RNA	NULL
helicases	NULL
.	NULL

It	NULL
seems	NULL
unlikely	NULL
that	NULL
a	NULL
change	NULL
in	NULL
the	NULL
carboxyl	NULL
terminus	NULL
of	NULL
XPB	NULL
such	NULL
as	NULL
in	NULL
XP11BE	NULL
modifies	NULL
the	NULL
composition	NULL
of	NULL
TFIIH	NULL
since	NULL
antibodies	NULL
against	NULL
both	NULL
the	NULL
wild-type	NULL
and	NULL
mutated	NULL
carboxyl	NULL
termini	NULL
of	NULL
XPB	NULL
immunoprecipitate	NULL
the	NULL
entire	NULL
TFIIH	NULL
.	NULL

Furthermore	NULL
,	NULL
immunoblot	NULL
analysis	NULL
demonstrates	NULL
that	NULL
the	NULL
composition	NULL
and	NULL
stoichiometry	NULL
of	NULL
TFIIHmut	NULL
and	NULL
TFIIHwt	NULL
are	NULL
identical	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

Finally	NULL
,	NULL
the	NULL
diminished	NULL
unwinding	NULL
capacity	NULL
is	NULL
also	NULL
observed	NULL
using	NULL
a	NULL
free	NULL
mutated	NULL
recombinant	NULL
XPB	NULL
protein	NULL
.	NULL

Therefore	NULL
,	NULL
a	NULL
conformational	NULL
modification	NULL
may	NULL
be	NULL
responsible	NULL
for	NULL
the	NULL
decrease	NULL
in	NULL
XPB	NULL
helicase	NULL
activity	NULL
.	NULL

It	NULL
is	NULL
worthwhile	NULL
to	NULL
note	NULL
the	NULL
profound	NULL
defect	NULL
not	NULL
only	NULL
of	NULL
the	NULL
helicase	NULL
activity	NULL
,	NULL
but	NULL
also	NULL
of	NULL
the	NULL
ATPase	NULL
activity	NULL
that	NULL
reside	NULL
in	NULL
the	NULL
XPB	NULL
recombinant	NULL
compared	NULL
with	NULL
purified	NULL
TFllHMmut	NULL
.	NULL

Although	NULL
the	NULL
ATPase	NULL
activity	NULL
was	NULL
affected	NULL
by	NULL
the	NULL
mutation	NULL
,	NULL
it	NULL
is	NULL
also	NULL
possible	NULL
that	NULL
the	NULL
defective	NULL
activity	NULL
is	NULL
due	NULL
to	NULL
an	NULL
incomplete	NULL
processing	NULL
or	NULL
to	NULL
the	NULL
fact	NULL
that	NULL
XPB	NULL
is	NULL
out	NULL
of	NULL
its	NULL
TFIIH	NULL
context	NULL
.	NULL

In	NULL
purified	NULL
TF	NULL
!	NULL

IHmut	NULL
,	NULL
a	NULL
deficiency	NULL
of	NULL
the	NULL
XPB	NULL
DNA-dependent	NULL
ATPase	NULL
activity	NULL
was	NULL
not	NULL
detected	NULL
.	NULL

Indeed	NULL
,	NULL
such	NULL
a	NULL
decrease	NULL
may	NULL
be	NULL
masked	NULL
by	NULL
the	NULL
XPD	NULL
ATPase	NULL
activity	NULL
.	NULL

Different	NULL
Levels	NULL
of	NULL
Inhibition	NULL
between	NULL
the	NULL
Repair	NULL
and	NULL
Transcription	NULL
Functions-The	NULL
XPB	NULL
function	NULL
has	NULL
to	NULL
be	NULL
considered	NULL
in	NULL
the	NULL
context	NULL
of	NULL
the	NULL
whole	NULL
TFIIH	NULL
.	NULL

(	NULL
i	NULL
)	NULL
Free	NULL
XPB	NULL
was	NULL
never	NULL
detected	NULL
in	NULL
the	NULL
various	NULL
protein	NULL
subfractions	NULL
generated	NULL
during	NULL
TFIIH	NULL
purification	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

TFIIH	NULL
is	NULL
absolutely	NULL
required	NULL
for	NULL
both	NULL
the	NULL
in	NULL
vitro	NULL
transcription	NULL
and	NULL
the	NULL
in	NULL
vitro	NULL
NER	NULL
reaction	NULL
(	NULL
14	NULL
,	NULL
15	NULL
,	NULL
30	NULL
,	NULL
32	NULL
,	NULL
33	NULL
)	NULL
,	NULL
and	NULL
the	NULL
addition	NULL
of	NULL
the	NULL
recombinant	NULL
subunit	NULL
to	NULL
the	NULL
TFIIH-lacking	NULL
reaction	NULL
mixture	NULL
has	NULL
no	NULL
effect	NULL
.	NULL

(	NULL
ii	NULL
)	NULL
Microinjection	NULL
of	NULL
antibodies	NULL
against	NULL
any	NULL
of	NULL
the	NULL
TFIIH	NULL
polypeptides	NULL
(	NULL
p89/XPB	NULL
,	NULL
p80/XPD	NULL
,	NULL
p44	NULL
,	NULL
and	NULL
MO15	NULL
)	NULL
into	NULL
normal	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
A	NULL
3	NULL
'	NULL
-5	NULL
'	NULL
XPB	NULL
Helicase	NULL
Defect	NULL
in	NULL
TFIIH	NULL
TEHH	NULL
wt	NULL
-	NULL
TFRHH	NULL
mut	NULL
Mo	NULL
--	NULL
-	NULL
]	NULL
«	NULL
-	NULL
am	NULL
.	NULL

@	NULL
»	NULL
aP	NULL
-pSO/XPD	NULL
-o	NULL
-	NULL
o	NULL
--	NULL
-p80/XPD	NULL
c-	NULL
»	NULL
ast	NULL
_	NULL
cme	NULL
«	NULL
«	NULL
#	NULL
--	NULL
pG2/TCD|	NULL
-	NULL
ca	NULL
owe	NULL
@	NULL
-MO15	NULL
quee	NULL
came	NULL
—2	NULL
-cyclin	NULL
H	NULL
1	NULL
2	NULL
3	NULL
4	NULL
Fig	NULL
.	NULL

5	NULL
.	NULL

Western	NULL
blot	NULL
analysis	NULL
of	NULL
TFIIHwt	NULL
(	NULL
7	NULL
ng/g	NULL
!	NULL
)	NULL

and	NULL
TFIIHmut	NULL
(	NULL
7	NULL
ng/pl	NULL
)	NULL
eluted	NULL
from	NULL
the	NULL
heparin	NULL
column	NULL
using	NULL
the	NULL
antibodies	NULL
against	NULL
p89/XPB	NULL
,	NULL
p80	NULL
,	NULL
p62	NULL
,	NULL
p44	NULL
,	NULL
MO15	NULL
,	NULL
and	NULL
cyclin	NULL
H.	NULL
Lanes	NULL
1	NULL
and	NULL
2	NULL
,	NULL
1	NULL
and	NULL
2	NULL
ul	NULL
of	NULL
TFIIHwt	NULL
,	NULL
respectively	NULL
;	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
,	NULL
1	NULL
and	NULL
2	NULL
pl	NULL
of	NULL
TFIIHmut	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
Zines	NULL
indicate	NULL
each	NULL
subunit	NULL
of	NULL
TFIIH	NULL
.	NULL

cell	NULL
lines	NULL
inhibits	NULL
both	NULL
in	NULL
vivo	NULL
NER	NULL
and	NULL
in	NULL
vivo	NULL
transcription	NULL
.	NULL

The	NULL
same	NULL
antibodies	NULL
are	NULL
able	NULL
to	NULL
deplete	NULL
crude	NULL
extracts	NULL
used	NULL
for	NULL
in	NULL
vitro	NULL
assays	NULL
(	NULL
10	NULL
,	NULL
13	NULL
,	NULL
14	NULL
)	NULL
.	NULL

(	NULL
iii	NULL
)	NULL
TFIIH	NULL
contains	NULL
at	NULL
least	NULL
four	NULL
subunits	NULL
(	NULL
XPB	NULL
,	NULL
XPD	NULL
,	NULL
p62/TFB1-like	NULL
,	NULL
and	NULL
p44/SSL1-like	NULL
)	NULL
that	NULL
were	NULL
shown	NULL
to	NULL
play	NULL
a	NULL
role	NULL
in	NULL
DNA	NULL
repair	NULL
(	NULL
6	NULL
,	NULL
7	NULL
,	NULL
18	NULL
)	NULL
.	NULL

The	NULL
DNA	NULL
repair	NULL
synthesis	NULL
in	NULL
XP11BE-derived	NULL
cells	NULL
is	NULL
only	NULL
5-10	NULL
%	NULL
of	NULL
that	NULL
in	NULL
normal	NULL
fibroblasts	NULL
,	NULL
and	NULL
TFIIHmut	NULL
is	NULL
not	NULL
able	NULL
to	NULL
restore	NULL
the	NULL
DNA	NULL
repair	NULL
reaction	NULL
,	NULL
neither	NULL
when	NULL
added	NULL
in	NULL
the	NULL
reconstituted	NULL
in	NULL
vitro	NULL
NER	NULL
system	NULL
nor	NULL
when	NULL
microinjected	NULL
into	NULL
cells	NULL
derived	NULL
from	NULL
another	NULL
XP-B	NULL
patient	NULL
(	NULL
XPCS1BA	NULL
)	NULL
.	NULL

In	NULL
basal	NULL
transcription	NULL
,	NULL
the	NULL
inhibition	NULL
rate	NULL
is	NULL
~30	NULL
%	NULL
.	NULL

Although	NULL
some	NULL
variation	NULL
is	NULL
intrinsic	NULL
to	NULL
transcription	NULL
activity	NULL
measurements	NULL
,	NULL
our	NULL
studies	NULL
demonstrate	NULL
a	NULL
consistent	NULL
decrease	NULL
in	NULL
TFIIH	NULL
transcription	NULL
stimulation	NULL
with	NULL
the	NULL
mutant	NULL
complex	NULL
.	NULL

Obviously	NULL
,	NULL
this	NULL
can	NULL
be	NULL
due	NULL
to	NULL
a	NULL
higher	NULL
in	NULL
vitro	NULL
lability	NULL
of	NULL
the	NULL
complex	NULL
,	NULL
e.g	NULL
.	NULL

during	NULL
purification	NULL
.	NULL

However	NULL
,	NULL
our	NULL
finding	NULL
that	NULL
the	NULL
composition	NULL
and	NULL
stoichiometry	NULL
of	NULL
the	NULL
complex	NULL
were	NULL
unaffected	NULL
and	NULL
that	NULL
the	NULL
other	NULL
activities	NULL
(	NULL
kinase	NULL
and	NULL
DNA-dependent	NULL
ATPase	NULL
)	NULL
were	NULL
very	NULL
similar	NULL
compared	NULL
with	NULL
control	NULL
TFIIH	NULL
isolated	NULL
in	NULL
parallel	NULL
argues	NULL
against	NULL
this	NULL
explanation	NULL
.	NULL

Thus	NULL
,	NULL
we	NULL
believe	NULL
that	NULL
the	NULL
decreased	NULL
in	NULL
vitro	NULL
transcription	NULL
activity	NULL
reflects	NULL
a	NULL
true	NULL
consequence	NULL
of	NULL
the	NULL
primary	NULL
mutation	NULL
in	NULL
the	NULL
XPB	NULL
protein	NULL
.	NULL

In	NULL
relation	NULL
to	NULL
this	NULL
,	NULL
it	NULL
is	NULL
worth	NULL
mentioning	NULL
that	NULL
the	NULL
doubling	NULL
time	NULL
of	NULL
the	NULL
mutated	NULL
XPB	NULL
cell	NULL
culture	NULL
is	NULL
also	NULL
significantly	NULL
higher	NULL
than	NULL
that	NULL
of	NULL
the	NULL
mother	NULL
's	NULL
control	NULL
cells	NULL
grown	NULL
under	NULL
identical	NULL
conditions	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Although	NULL
this	NULL
could	NULL
obviously	NULL
be	NULL
due	NULL
to	NULL
other	NULL
trivial	NULL
differences	NULL
,	NULL
the	NULL
subtle	NULL
transcription	NULL
defect	NULL
may	NULL
also	NULL
be	NULL
the	NULL
underlying	NULL
cause	NULL
.	NULL

This	NULL
observation	NULL
is	NULL
also	NULL
in	NULL
line	NULL
with	NULL
the	NULL
severe	NULL
growth	NULL
defect	NULL
displayed	NULL
by	NULL
patient	NULL
XP11BE	NULL
(	NULL
24	NULL
)	NULL
.	NULL

The	NULL
finding	NULL
that	NULL
the	NULL
effect	NULL
of	NULL
the	NULL
mutation	NULL
in	NULL
XPB	NULL
is	NULL
much	NULL
more	NULL
dramatic	NULL
for	NULL
the	NULL
NER	NULL
function	NULL
than	NULL
for	NULL
transcription	NULL
may	NULL
be	NULL
explained	NULL
in	NULL
different	NULL
ways	NULL
.	NULL

The	NULL
XPB	NULL
helicase	NULL
faces	NULL
different	NULL
DNA	NULL
substrates	NULL
in	NULL
each	NULL
process	NULL
.	NULL

In	NULL
transcription	NULL
,	NULL
TFIIH	NULL
will	NULL
target	NULL
a	NULL
promoter	NULL
that	NULL
includes	NULL
specific	NULL
sequences	NULL
such	NULL
as	NULL
a	NULL
TATA	NULL
box	NULL
and	NULL
an	NULL
initiator	NULL
site	NULL
as	NULL
well	NULL
as	NULL
a	NULL
number	NULL
of	NULL
other	NULL
basal	NULL
transcription	NULL
factors	NULL
(	NULL
3	NULL
)	NULL
.	NULL

In	NULL
NER	NULL
,	NULL
TFIIH	NULL
is	NULL
thought	NULL
to	NULL
act	NULL
at	NULL
an	NULL
early	NULL
stage	NULL
in	NULL
the	NULL
reaction	NULL
where	NULL
it	NULL
is	NULL
required	NULL
for	NULL
the	NULL
elimination	NULL
of	NULL
,	NULL
for	NULL
example	NULL
,	NULL
UV-induced	NULL
(	NULL
6-4	NULL
)	NULL
photoproducts	NULL
or	NULL
cyclobutane	NULL
pyrimidine	NULL
dimers	NULL
.	NULL

In	NULL
both	NULL
reactions	NULL
,	NULL
the	NULL
function	NULL
of	NULL
the	NULL
complex	NULL
may	NULL
be	NULL
the	NULL
local	NULL
opening	NULL
of	NULL
the	NULL
DNA	NULL
helix	NULL
,	NULL
but	NULL
the	NULL
requirements	NULL
for	NULL
this	NULL
activity	NULL
may	NULL
be	NULL
different	NULL
for	NULL
both	NULL
processes	NULL
.	NULL

The	NULL
change	NULL
in	NULL
the	NULL
carboxyl	NULL
terminus	NULL
of	NULL
XPB	NULL
may	NULL
prevent	NULL
the	NULL
binding	NULL
of	NULL
other	NULL
repair	NULL
factors	NULL
,	NULL
but	NULL
may	NULL
induce	NULL
only	NULL
a	NULL
slight	NULL
effect	NULL
on	NULL
the	NULL
opening	NULL
of	NULL
the	NULL
DNA	NULL
template	NULL
at	NULL
the	NULL
promoter	NULL
level	NULL
.	NULL

This	NULL
would	NULL
result	NULL
in	NULL
a	NULL
limited	NULL
decrease	NULL
in	NULL
the	NULL
rate	NULL
of	NULL
basal	NULL
transcription	NULL
.	NULL

Another	NULL
possibility	NULL
is	NULL
that	NULL
XPBmut	NULL
is	NULL
compensated	NULL
by	NULL
XPD	NULL
,	NULL
another	NULL
helicase	NULL
associated	NULL
with	NULL
TFIIH	NULL
.	NULL

Clinical	NULL
Consequences	NULL
and	NULL
Putative	NULL
Mechanisms-Some	NULL
of	NULL
the	NULL
clinical	NULL
symptoms	NULL
of	NULL
patient	NULL
XP11BE	NULL
can	NULL
not	NULL
be	NULL
simply	NULL
explained	NULL
on	NULL
the	NULL
basis	NULL
of	NULL
NER	NULL
deficiency	NULL
.	NULL

The	NULL
typical	NULL
XP	NULL
clin-	NULL
15908	NULL
ical	NULL
features	NULL
such	NULL
as	NULL
sun	NULL
hypersensitivity	NULL
and	NULL
cancer	NULL
predisposition	NULL
are	NULL
likely	NULL
derived	NULL
from	NULL
a	NULL
repair	NULL
defect	NULL
.	NULL

The	NULL
remaining	NULL
features	NULL
such	NULL
as	NULL
the	NULL
neuromyelination	NULL
defect	NULL
,	NULL
stunted	NULL
growth	NULL
,	NULL
and	NULL
impaired	NULL
sexual	NULL
development	NULL
are	NULL
likely	NULL
due	NULL
to	NULL
a	NULL
crippled	NULL
transcription	NULL
function	NULL
.	NULL

In	NULL
the	NULL
latter	NULL
case	NULL
,	NULL
a	NULL
subtle	NULL
mutation	NULL
in	NULL
XPB	NULL
as	NULL
observed	NULL
here	NULL
may	NULL
prevent	NULL
the	NULL
interaction	NULL
between	NULL
TFIIH	NULL
and	NULL
either	NULL
the	NULL
promoter	NULL
or	NULL
components	NULL
of	NULL
basal	NULL
or	NULL
activated	NULL
transcription	NULL
machinery	NULL
(	NULL
e.g	NULL
.	NULL

TFIIE	NULL
(	NULL
34	NULL
)	NULL
,	NULL
Gal-VP16	NULL
(	NULL
35	NULL
)	NULL
,	NULL
and	NULL
p53	NULL
(	NULL
36	NULL
)	NULL
)	NULL
.	NULL

As	NULL
a	NULL
consequence	NULL
,	NULL
transcription	NULL
of	NULL
a	NULL
specific	NULL
subset	NULL
of	NULL
genes	NULL
may	NULL
be	NULL
critically	NULL
hampered	NULL
,	NULL
impairing	NULL
specialized	NULL
functions	NULL
and	NULL
,	NULL
for	NULL
example	NULL
,	NULL
general	NULL
development	NULL
(	NULL
see	NULL
Refs	NULL
.	NULL

20	NULL
and	NULL
21	NULL
for	NULL
a	NULL
more	NULL
extensive	NULL
discussion	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
our	NULL
work	NULL
defines	NULL
the	NULL
enzymatic	NULL
defects	NULL
of	NULL
a	NULL
TFIIH	NULL
mutant	NULL
in	NULL
3	NULL
'	NULL
-	NULL
>	NULL
5	NULL
'	NULL
XPB	NULL
helicase	NULL
,	NULL
NER	NULL
,	NULL
and	NULL
transcription	NULL
activities	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
it	NULL
provides	NULL
the	NULL
first	NULL
biochemical	NULL
evidence	NULL
for	NULL
inherited	NULL
deficiencies	NULL
within	NULL
the	NULL
human	NULL
population	NULL
in	NULL
one	NULL
of	NULL
the	NULL
most	NULL
fundamental	NULL
cellular	NULL
processes	NULL
,	NULL
basal	NULL
transcription	NULL
.	NULL

Obviously	NULL
,	NULL
the	NULL
translation	NULL
of	NULL
the	NULL
molecular	NULL
defect	NULL
into	NULL
any	NULL
of	NULL
the	NULL
individual	NULL
symptoms	NULL
comprising	NULL
the	NULL
complex	NULL
and	NULL
pleiotro-pic	NULL
CS	NULL
and	NULL
TTD	NULL
phenotypes	NULL
awaits	NULL
the	NULL
generation	NULL
of	NULL
experimental	NULL
mouse	NULL
models	NULL
for	NULL
these	NULL
disorders	NULL
and	NULL
a	NULL
more	NULL
precise	NULL
definition	NULL
of	NULL
the	NULL
role	NULL
of	NULL
TFIIH	NULL
in	NULL
transcription	NULL
.	NULL

Work	NULL
along	NULL
both	NULL
lines	NULL
of	NULL
research	NULL
is	NULL
ongoing	NULL
.	NULL

Acknowledgments-We	NULL
thank	NULL
P.	NULL
Chambon	NULL
and	NULL
D.	NULL
Bootsma	NULL
for	NULL
continuous	NULL
support	NULL
and	NULL
P.	NULL
Vichi	NULL
,	NULL
S.	NULL
Humbert	NULL
,	NULL
R.	NULL
Roy	NULL
,	NULL
R.	NULL
Fraser	NULL
,	NULL
and	NULL
G.	NULL
Weeda	NULL
for	NULL
fruitful	NULL
discussions	NULL
and	NULL
comments	NULL
on	NULL
the	NULL
manuscript	NULL
.	NULL

We	NULL
also	NULL
thank	NULL
Y.	NULL
Lutz	NULL
for	NULL
antibody	NULL
production	NULL
and	NULL
cell	NULL
culture	NULL
team	NULL
.	NULL

REFERENCES	NULL
.	NULL

Gil	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
Tjian	NULL
,	NULL
R.	NULL
(	NULL
1992	NULL
)	NULL
Curr	NULL
.	NULL

Opin	NULL
.	NULL

Gen.	NULL
&	NULL
Dev	NULL
.	NULL

2	NULL
,	NULL
236-242	NULL
.	NULL

Zawel	NULL
,	NULL
L.	NULL
,	NULL
and	NULL
Reinberg	NULL
,	NULL
D.	NULL
(	NULL
1992	NULL
)	NULL
Curr	NULL
.	NULL

Opin	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

4	NULL
,	NULL
488-495	NULL
.	NULL

Conaway	NULL
,	NULL
R.	NULL
C.	NULL
,	NULL
and	NULL
Conaway	NULL
,	NULL
J.	NULL
W.	NULL
(	NULL
1993	NULL
)	NULL
Annu	NULL
.	NULL

Rev	NULL
.	NULL

Biochem	NULL
.	NULL

62	NULL
,	NULL
161-190	NULL
.	NULL

Drapkin	NULL
,	NULL
R.	NULL
,	NULL
Sancar	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Reinberg	NULL
,	NULL
D.	NULL
(	NULL
1994	NULL
)	NULL
Cell	NULL
77	NULL
,	NULL
9-12	NULL
.	NULL

Seroz	NULL
,	NULL
T.	NULL
,	NULL
Hwang	NULL
,	NULL
J.	NULL
R.	NULL
,	NULL
Moncollin	NULL
,	NULL
V.	NULL
,	NULL
and	NULL
Eigly	NULL
,	NULL
J.	NULL
M.	NULL
(	NULL
1995	NULL
)	NULL
Curr	NULL
.	NULL

Opin	NULL
.	NULL

Genet	NULL
.	NULL

&	NULL
Dev	NULL
.	NULL

5	NULL
,	NULL
217-221	NULL
.	NULL

Schaeffer	NULL
,	NULL
L.	NULL
,	NULL
Roy	NULL
,	NULL
R.	NULL
,	NULL
Humbert	NULL
,	NULL
S.	NULL
,	NULL
Moncollin	NULL
,	NULL
V.	NULL
,	NULL
Vermeulen	NULL
,	NULL
W.	NULL
,	NULL
Hoeijmakers	NULL
,	NULL
J.	NULL
H.	NULL
J.	NULL
,	NULL
Chambon	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Egly	NULL
,	NULL
J.	NULL
M.	NULL
(	NULL
1993	NULL
)	NULL
Science	NULL
260	NULL
,	NULL
58-63	NULL
7	NULL
.	NULL

Schaeffer	NULL
,	NULL
L.	NULL
,	NULL
Moncollin	NULL
,	NULL
V.	NULL
,	NULL
Roy	NULL
,	NULL
R.	NULL
,	NULL
Staub	NULL
,	NULL
A.	NULL
,	NULL
Mezzina	NULL
,	NULL
M.	NULL
,	NULL
Sarasin	NULL
,	NULL
A.	NULL
,	NULL
Weeda	NULL
,	NULL
G.	NULL
,	NULL
Hoeijmakers	NULL
,	NULL
J.	NULL
H.	NULL
J.	NULL
,	NULL
and	NULL
Egly	NULL
,	NULL
J.	NULL
M.	NULL
(	NULL
1994	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

13	NULL
,	NULL
2388-2392	NULL
8	NULL
.	NULL

Sung	NULL
,	NULL
P.	NULL
,	NULL
Bailly	NULL
,	NULL
V.	NULL
,	NULL
Weber	NULL
,	NULL
C.	NULL
,	NULL
Thompson	NULL
,	NULL
L.	NULL
H.	NULL
,	NULL
Prakash	NULL
,	NULL
L.	NULL
,	NULL
and	NULL
Prakash	NULL
,	NULL
S.	NULL
(	NULL
1994	NULL
)	NULL
Nature	NULL
865	NULL
,	NULL
852-855	NULL
9	NULL
.	NULL

Serizawa	NULL
,	NULL
H.	NULL
,	NULL
Conaway	NULL
,	NULL
R.	NULL
C.	NULL
,	NULL
and	NULL
Conaway	NULL
,	NULL
J.	NULL
W.	NULL
(	NULL
1993	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268	NULL
,	NULL
17300-17308	NULL
10	NULL
.	NULL

Roy	NULL
,	NULL
R.	NULL
,	NULL
Adamezewski	NULL
,	NULL
J.	NULL
P.	NULL
,	NULL
Seroz	NULL
,	NULL
T.	NULL
,	NULL
Vermeulen	NULL
,	NULL
W.	NULL
,	NULL
Tassan	NULL
,	NULL
J.	NULL
P.	NULL
,	NULL
Schaeffer	NULL
,	NULL
L.	NULL
,	NULL
Nigg	NULL
,	NULL
E.	NULL
A.	NULL
,	NULL
Hoeijmakers	NULL
,	NULL
J.	NULL
H.	NULL
J.	NULL
,	NULL
and	NULL
Egly	NULL
,	NULL
J.	NULL
M.	NULL
(	NULL
1994	NULL
)	NULL
Cell	NULL
79	NULL
,	NULL
1093-1101	NULL
11	NULL
.	NULL

Fisher	NULL
,	NULL
R.	NULL
P.	NULL
,	NULL
and	NULL
Morgan	NULL
,	NULL
D.	NULL
O	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Cell	NULL
78	NULL
,	NULL
718-724	NULL
12	NULL
.	NULL

Yoon	NULL
,	NULL
H.	NULL
,	NULL
Miller	NULL
,	NULL
S.	NULL
P.	NULL
,	NULL
Pabich	NULL
,	NULL
E.	NULL
K.	NULL
,	NULL
and	NULL
Donahue	NULL
,	NULL
T.	NULL
F.	NULL
(	NULL
1992	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

6	NULL
,	NULL
2463-2477	NULL
13	NULL
.	NULL

Humbert	NULL
,	NULL
S.	NULL
,	NULL
van	NULL
Vuuren	NULL
,	NULL
H.	NULL
,	NULL
Luts	NULL
,	NULL
Y.	NULL
,	NULL
Hoeijmakers	NULL
,	NULL
J.	NULL
H.	NULL
J.	NULL
,	NULL
Egly	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
and	NULL
.	NULL

Moncollin	NULL
,	NULL
V.	NULL
(	NULL
1994	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

13	NULL
,	NULL
2398-2398	NULL
14.	NULL
van	NULL
Vuuren	NULL
,	NULL
A.	NULL
J.	NULL
,	NULL
Vermeulen	NULL
,	NULL
W.	NULL
,	NULL
Ma	NULL
,	NULL
L.	NULL
,	NULL
Weeda	NULL
,	NULL
G.	NULL
,	NULL
Appeldoorn	NULL
,	NULL
E.	NULL
,	NULL
Jaspers	NULL
,	NULL
N.	NULL
G.	NULL
J.	NULL
,	NULL
van	NULL
der	NULL
Eb	NULL
,	NULL
A.	NULL
J.	NULL
,	NULL
Bootsma	NULL
,	NULL
D.	NULL
,	NULL
Hoeijmakers	NULL
,	NULL
J.	NULL
H.	NULL
J.	NULL
,	NULL
Humbert	NULL
,	NULL
S.	NULL
,	NULL
Schaeffer	NULL
,	NULL
L.	NULL
,	NULL
and	NULL
Egly	NULL
,	NULL
J.	NULL
M.	NULL
(	NULL
1994	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

18	NULL
,	NULL
1645-1653	NULL
15	NULL
.	NULL

Guzder	NULL
,	NULL
S.	NULL
N.	NULL
,	NULL
Habraken	NULL
,	NULL
Y.	NULL
,	NULL
Sung	NULL
,	NULL
P.	NULL
,	NULL
Prakash	NULL
,	NULL
L.	NULL
,	NULL
and	NULL
Prakash	NULL
,	NULL
S.	NULL
(	NULL
1995	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
,	NULL
12973-12976	NULL
16	NULL
.	NULL

Aboussekhra	NULL
,	NULL
A.	NULL
,	NULL
Biggerstaff	NULL
,	NULL
M.	NULL
,	NULL
Shivji	NULL
,	NULL
M.	NULL
K.	NULL
K.	NULL
,	NULL
Vilpo	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Moncollin	NULL
,	NULL
V.	NULL
,	NULL
Podust	NULL
,	NULL
V.	NULL
N.	NULL
,	NULL
Protic	NULL
,	NULL
M.	NULL
,	NULL
Hiibscher	NULL
,	NULL
U.	NULL
,	NULL
Eigly	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
and	NULL
Wood	NULL
,	NULL
R.	NULL
D.	NULL
(	NULL
1995	NULL
)	NULL
Cell	NULL
80	NULL
,	NULL
859-868	NULL
17	NULL
.	NULL

Mu	NULL
,	NULL
D.	NULL
,	NULL
Park	NULL
,	NULL
C.	NULL
H.	NULL
,	NULL
Matsunaga	NULL
,	NULL
T.	NULL
,	NULL
Hsu	NULL
,	NULL
D.	NULL
S.	NULL
,	NULL
Reardon	NULL
,	NULL
J.	NULL
T.	NULL
,	NULL
and	NULL
Sancar	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
,	NULL
2415-2418	NULL
18	NULL
.	NULL

Wang	NULL
,	NULL
Z.	NULL
,	NULL
Buratowski	NULL
,	NULL
S.	NULL
,	NULL
Svejstrup	NULL
,	NULL
J.	NULL
Q.	NULL
,	NULL
Feaver	NULL
,	NULL
W.	NULL
J.	NULL
,	NULL
Wu	NULL
,	NULL
X.	NULL
,	NULL
Kornberg	NULL
,	NULL
R.	NULL
D.	NULL
,	NULL
Donahue	NULL
,	NULL
T.	NULL
F.	NULL
,	NULL
and	NULL
Friedberg	NULL
,	NULL
E.	NULL
C.	NULL
(	NULL
1995	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15	NULL
,	NULL
2288-2293	NULL
19	NULL
.	NULL

Huang	NULL
,	NULL
J.	NULL
C.	NULL
,	NULL
Svoboda	NULL
,	NULL
D.	NULL
L.	NULL
,	NULL
Reardon	NULL
,	NULL
J.	NULL
T.	NULL
,	NULL
and	NULL
Sancar	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

89	NULL
,	NULL
3664-3668	NULL
20	NULL
.	NULL

Hoeijmakers	NULL
,	NULL
J.	NULL
H.	NULL
J	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Eur	NULL
.	NULL

J	NULL
.	NULL

Cancer	NULL
80	NULL
,	NULL
1912-1921	NULL
21	NULL
.	NULL

Bootsma	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
Hoeijmakers	NULL
,	NULL
J.	NULL
H.	NULL
J	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Nature	NULL
868	NULL
,	NULL
114-115	NULL
22	NULL
.	NULL

Vermeulen	NULL
,	NULL
W.	NULL
,	NULL
van	NULL
Vuuren	NULL
,	NULL
A.	NULL
J.	NULL
,	NULL
Chipoulet	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Schaeffer	NULL
,	NULL
L.	NULL
,	NULL
Appeldoorn	NULL
,	NULL
E.	NULL
,	NULL
Weeda	NULL
,	NULL
G.	NULL
,	NULL
Jaspers	NULL
,	NULL
N.	NULL
G.	NULL
J.	NULL
,	NULL
Priestley	NULL
,	NULL
A.	NULL
,	NULL
Arlett	NULL
,	NULL
C.	NULL
F.	NULL
,	NULL
Lehmann	NULL
,	NULL
A.	NULL
R.	NULL
,	NULL
Stefanini	NULL
,	NULL
M.	NULL
,	NULL
Mezzina	NULL
,	NULL
M.	NULL
,	NULL
Sarasin	NULL
,	NULL
A.	NULL
,	NULL
Bootsma	NULL
,	NULL
D.	NULL
,	NULL
Eigly	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
and	NULL
Hoeijmakers	NULL
,	NULL
J.	NULL
H.	NULL
J	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
Symp	NULL
.	NULL

Ser	NULL
.	NULL

59	NULL
,	NULL
817-329	NULL
23	NULL
.	NULL

Weeda	NULL
,	NULL
G.	NULL
,	NULL
van	NULL
Ham	NULL
,	NULL
R.	NULL
C.	NULL
A.	NULL
,	NULL
Vermeulen	NULL
,	NULL
W.	NULL
,	NULL
Bootsma	NULL
,	NULL
D.	NULL
,	NULL
van	NULL
der	NULL
Eb	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Hoeijmakers	NULL
,	NULL
J.	NULL
H.	NULL
J	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Cell	NULL
62	NULL
,	NULL
777-791	NULL
24	NULL
.	NULL

Cleaver	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
and	NULL
Kraemer	NULL
,	NULL
K.	NULL
H.	NULL
(	NULL
1994	NULL
)	NULL
in	NULL
The	NULL
Metabolic	NULL
and	NULL
Molecular	NULL
Bases	NULL
of	NULL
Inherited	NULL
Disease	NULL
(	NULL
Scriver	NULL
,	NULL
C.	NULL
R.	NULL
,	NULL
Beaudet	NULL
,	NULL
A.	NULL
L.	NULL
,	NULL
Sly	NULL
,	NULL
W.	NULL
S.	NULL
,	NULL
and	NULL
Valle	NULL
,	NULL
D.	NULL
,	NULL
eds	NULL
)	NULL
Vol	NULL
.	NULL

III	NULL
,	NULL
pp	NULL
.	NULL

4393-4419	NULL
,	NULL
McGraw-Hill	NULL
Inc.	NULL
,	NULL
New	NULL
York	NULL
25	NULL
.	NULL

Friedberg	NULL
,	NULL
E.	NULL
C.	NULL
,	NULL
Walker	NULL
,	NULL
G.	NULL
C.	NULL
,	NULL
and	NULL
Siede	NULL
,	NULL
W.	NULL
(	NULL
1995	NULL
)	NULL
DNA	NULL
Repair	NULL
and	NULL
Mutagenesis	NULL
,	NULL
American	NULL
Society	NULL
for	NULL
Microbiology	NULL
,	NULL
Washington	NULL
,	NULL
D.	NULL
C.	NULL
26	NULL
.	NULL

Hoeijmakers	NULL
,	NULL
J.	NULL
H.	NULL
J	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Trends	NULL
Genet	NULL
.	NULL

9	NULL
,	NULL
211-217	NULL
Oum	NULL
0	NULL
N	NULL
19	NULL
&	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
15904	NULL
27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33.	NULL
van	NULL
Vuuren	NULL
,	NULL
A.	NULL
J.	NULL
,	NULL
Appeldocorn	NULL
,	NULL
E.	NULL
,	NULL
Odijk	NULL
,	NULL
H.	NULL
,	NULL
Yasui	NULL
,	NULL
A.	NULL
,	NULL
Jaspers	NULL
,	NULL
N.	NULL
G.	NULL
J.	NULL
,	NULL
Bootsma	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
Hoeijmakers	NULL
,	NULL
J.	NULL
H.	NULL
J	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

12	NULL
,	NULL
3693-3701	NULL
Chalut	NULL
,	NULL
C.	NULL
,	NULL
Lang	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Egly	NULL
,	NULL
J.	NULL
M.	NULL
(	NULL
1994	NULL
)	NULL
Protein	NULL
Expression	NULL
Purif	NULL
.	NULL

5	NULL
,	NULL
458-467	NULL
Roy	NULL
,	NULL
R.	NULL
,	NULL
Schaeffer	NULL
,	NULL
L.	NULL
,	NULL
Humbert	NULL
,	NULL
S.	NULL
,	NULL
Vermeulen	NULL
,	NULL
W.	NULL
,	NULL
Weeda	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
Egly	NULL
,	NULL
J.	NULL
M.	NULL
(	NULL
1994	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269	NULL
,	NULL
9826-9832	NULL
Gérard	NULL
,	NULL
M.	NULL
,	NULL
Fischer	NULL
,	NULL
L.	NULL
,	NULL
Moncollin	NULL
,	NULL
V.	NULL
,	NULL
Chipoulet	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Chambon	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Eigly	NULL
,	NULL
J.	NULL
M.	NULL
(	NULL
1991	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

266	NULL
,	NULL
20940-20945	NULL
Ma	NULL
,	NULL
L.	NULL
,	NULL
Westbroek	NULL
,	NULL
A.	NULL
,	NULL
Jochemsen	NULL
,	NULL
A.	NULL
G.	NULL
,	NULL
Weeda	NULL
,	NULL
G.	NULL
,	NULL
Bosch	NULL
,	NULL
A.	NULL
,	NULL
Bootsma	NULL
,	NULL
D.	NULL
,	NULL
Hoeijmakers	NULL
,	NULL
J.	NULL
H.	NULL
J.	NULL
,	NULL
and	NULL
van	NULL
der	NULL
Eb	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14	NULL
,	NULL
4126-4134	NULL
Conaway	NULL
,	NULL
R.	NULL
C.	NULL
,	NULL
and	NULL
Conaway	NULL
,	NULL
J.	NULL
W.	NULL
(	NULL
1989	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

86	NULL
,	NULL
7356-7360	NULL
Feaver	NULL
,	NULL
W.	NULL
J.	NULL
,	NULL
Svejstrup	NULL
,	NULL
J.	NULL
Q.	NULL
,	NULL
Bardwell	NULL
,	NULL
L.	NULL
,	NULL
Buratowski	NULL
,	NULL
S.	NULL
,	NULL
Gulyas	NULL
,	NULL
K.	NULL
D.	NULL
,	NULL
34	NULL
.	NULL

35	NULL
38	NULL
A	NULL
3	NULL
'	NULL
-5	NULL
'	NULL
XPB	NULL
Helicase	NULL
Defect	NULL
in	NULL
TFIIH	NULL
Donahue	NULL
,	NULL
T.	NULL
F.	NULL
,	NULL
Friedberg	NULL
,	NULL
E.	NULL
C.	NULL
,	NULL
and	NULL
Kornberg	NULL
,	NULL
R.	NULL
D.	NULL
(	NULL
1993	NULL
)	NULL
Cell	NULL
75	NULL
,	NULL
1379-1387	NULL
.	NULL

Ohkuma	NULL
,	NULL
Y.	NULL
,	NULL
and	NULL
Roeder	NULL
,	NULL
R.	NULL
G.	NULL
(	NULL
1994	NULL
)	NULL
Nature	NULL
368	NULL
,	NULL
160-163	NULL
.	NULL

Xiao	NULL
,	NULL
H.	NULL
,	NULL
Pearson	NULL
,	NULL
A.	NULL
,	NULL
Coulombe	NULL
,	NULL
B.	NULL
,	NULL
Truant	NULL
,	NULL
R.	NULL
,	NULL
Zhang	NULL
,	NULL
S.	NULL
,	NULL
Regier	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
Triezenberg	NULL
,	NULL
S.	NULL
J.	NULL
,	NULL
Reinberg	NULL
,	NULL
D.	NULL
,	NULL
Flores	NULL
,	NULL
O.	NULL
,	NULL
Ingles	NULL
,	NULL
C.	NULL
J.	NULL
,	NULL
and	NULL
Greenblatt	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14	NULL
,	NULL
7018-7024	NULL
.	NULL

Wang	NULL
,	NULL
X.	NULL
W.	NULL
,	NULL
Yeh	NULL
,	NULL
H.	NULL
,	NULL
Schaeffer	NULL
,	NULL
L.	NULL
,	NULL
Roy	NULL
,	NULL
R.	NULL
,	NULL
Moncollin	NULL
,	NULL
V.	NULL
,	NULL
Egly	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Wang	NULL
,	NULL
Z.	NULL
,	NULL
Friedberg	NULL
,	NULL
E.	NULL
C.	NULL
,	NULL
Evans	NULL
,	NULL
M.	NULL
K.	NULL
,	NULL
Taffe	NULL
,	NULL
B.	NULL
G.	NULL
,	NULL
Bohr	NULL
,	NULL
V.	NULL
A.	NULL
,	NULL
Weeda	NULL
,	NULL
G.	NULL
,	NULL
Hoeijmakers	NULL
,	NULL
J.	NULL
H.	NULL
J.	NULL
,	NULL
Forrester	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Harris	NULL
,	NULL
C.	NULL
C.	NULL
(	NULL
1995	NULL
)	NULL
Nat	NULL
.	NULL

Genet	NULL
.	NULL

10	NULL
,	NULL
188-195	NULL
.	NULL

Fischer	NULL
,	NULL
L.	NULL
,	NULL
Gérard	NULL
,	NULL
M.	NULL
,	NULL
Chalut	NULL
,	NULL
C.	NULL
,	NULL
Lutz	NULL
,	NULL
Y.	NULL
,	NULL
Humbert	NULL
,	NULL
S.	NULL
,	NULL
Kanno	NULL
,	NULL
M.	NULL
,	NULL
Chambon	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Eigly	NULL
,	NULL
J.	NULL
M.	NULL
(	NULL
1992	NULL
)	NULL
Science	NULL
257	NULL
,	NULL
1392-1395	NULL
.	NULL

Tassan	NULL
,	NULL
J.	NULL
P.	NULL
,	NULL
Schultz	NULL
,	NULL
S.	NULL
J.	NULL
,	NULL
Bartek	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Nigg	NULL
,	NULL
E.	NULL
A	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
J	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

127	NULL
,	NULL
467-478	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
A	NULL
3	NULL
'	NULL
-	NULL
>	NULL
5	NULL
XPB	NULL
Helicase	NULL
Defect	NULL
in	NULL
Repair/Transcription	NULL
Factor	NULL
TFIIH	NULL
of	NULL
Xeroderma	NULL
Pigmentosum	NULL
Group	NULL
B	NULL
Affects	NULL
Both	NULL
DNA	NULL
Repair	NULL
and	NULL
Transcription	NULL
Jae	NULL
Ryoung	NULL
Hwang	NULL
,	NULL
Vincent	NULL
Moncollin	NULL
,	NULL
Wim	NULL
Vermeulen	NULL
,	NULL
Thierry	NULL
Seroz	NULL
,	NULL
Hanneke	NULL
van	NULL
Vuuren	NULL
,	NULL
Jan	NULL
H.	NULL
J.	NULL
Hoeijmakers	NULL
and	NULL
Jean	NULL
Marc	NULL
Egly	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

1996	NULL
,	NULL
271:15898-15904.	NULL
doi	NULL
:	NULL
10.1074/jb0.271.27.15898	NULL
Access	NULL
the	NULL
most	NULL
updated	NULL
version	NULL
of	NULL
this	NULL
article	NULL
at	NULL
http	NULL
:	NULL
/www.jbe.org/content/271/27/15898	NULL
Alerts	NULL
:	NULL
«	NULL
When	NULL
this	NULL
article	NULL
is	NULL
cited	NULL
«	NULL
When	NULL
a	NULL
correction	NULL
for	NULL
this	NULL
article	NULL
is	NULL
posted	NULL
Click	NULL
here	NULL
to	NULL
choose	NULL
from	NULL
all	NULL
of	NULL
JBC	NULL
's	NULL
e-mail	NULL
alerts	NULL
This	NULL
article	NULL
cites	NULL
37	NULL
references	NULL
,	NULL
14	NULL
of	NULL
which	NULL
can	NULL
be	NULL
accessed	NULL
free	NULL
at	NULL
http	NULL
:	NULL
//www	NULL
5898.	NULL
full.html	NULL
#	NULL
ref-list-1	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
4q	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL

